Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription factor binding	MAGEA2 ZNF703 ASXL1 MAGEA12 TCF12 BCAS3 NACA ZMYND8 GATA2 MED14 PER1 TFDP3 PPP1R13B RUNX1 FAF1 PPARGC1A NCOR2 SALL1 WIZ PER3 PTPRN KMT2A PAX2 VGLL4 SPEN TOX2 MED13 HTT	4.07e-10	753	186	28	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	MAGEA2 ZNF703 ASXL1 MAGEA12 TCF12 BCAS3 ZMYND8 GATA2 MED14 PER1 TFDP3 RUNX1 FAF1 PPARGC1A NCOR2 SALL1 KMT2A SPEN TOX2 MED13	5.49e-07	582	186	20	GO:0140297
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	5.38e-05	44	186	5	GO:0140938
GeneOntologyMolecularFunction	tau protein binding	MAP1A MAP2 TTBK1 MARK4 BRSK1	6.68e-05	46	186	5	GO:0048156
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF438 TCF12 ERG NTN3 GATA2 DACH1 TFDP3 ZNF619 RUNX1 RFX7 ZNF467 E2F8 PRDM2 HIVEP3 HEYL AHRR HOXC5 SALL2 SALL1 WIZ DBX1 ZNF358 ZNF197 PLAGL1 PAX2 MYRF FOXK1 FOXI1	1.19e-04	1412	186	28	GO:0000981
GeneOntologyMolecularFunction	chromatin binding	TICRR ASXL1 PCGF2 ERG EP400 BCAS3 GATA2 PER1 RUNX1 KDM6B PPARGC1A NCOR2 SALL1 TOX3 KMT2A TOX2 TOP2A BAHCC1	1.96e-04	739	186	18	GO:0003682
GeneOntologyMolecularFunction	tubulin binding	MAP1A MAP2 KIF26B BCAS3 WHAMM CCDC88C PPARGC1A RGS14 SETD2 STARD9 MARK4 BRSK1 HTT	1.96e-04	428	186	13	GO:0015631
GeneOntologyMolecularFunction	cytoskeletal protein binding	EPS8L2 MAP1A MAP2 KIF26B BCAS3 TPRN WASF3 SYNPO2L WHAMM GAS7 RCSD1 SYNPO CCDC88C PPARGC1A RGS14 SETD2 TTBK1 PTPRN STARD9 FARP1 MARK4 BRSK1 HTT	2.38e-04	1099	186	23	GO:0008092
GeneOntologyMolecularFunction	transcription coregulator activity	ASXL1 NACA ZMYND8 MED14 MED13L SRCAP PPARGC1A NCOR2 TOB1 PIAS3 TOX3 SPEN TOX2 MED13 PML	2.60e-04	562	186	15	GO:0003712
GeneOntologyMolecularFunction	protein-lysine N-methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	4.31e-04	68	186	5	GO:0016279
GeneOntologyMolecularFunction	lysine N-methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	4.61e-04	69	186	5	GO:0016278
GeneOntologyMolecularFunction	C2H2 zinc finger domain binding	GATA2 PAX2 SRRM2	4.91e-04	17	186	3	GO:0070742
GeneOntologyMolecularFunction	histone methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	5.26e-04	71	186	5	GO:0042054
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	ASXL1 BCAS3 GATA2 MED14 TFDP3 FAF1 PPARGC1A NCOR2 SALL1 SPEN TOX2 MED13	5.60e-04	417	186	12	GO:0061629
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	TCF12 ERG NTN3 GATA2 DACH1 PER1 TFDP3 RUNX1 KDM6B RFX7 ZNF467 E2F8 HIVEP3 HEYL HOXC5 SALL2 SALL1 WIZ ZNF358 ZNF197 PLAGL1 PAX2 FOXK1 FOXI1	7.62e-04	1271	186	24	GO:0000987
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2B SETBP1 KMT2A	8.07e-04	20	186	3	GO:0042800
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	TCF12 ERG NTN3 GATA2 DACH1 PER1 TFDP3 ZNF619 RUNX1 KDM6B RFX7 ZNF467 E2F8 PRDM2 HIVEP3 HEYL HOXC5 SALL2 SALL1 WIZ ZNF358 ZNF197 PLAGL1 PAX2 FOXK1 FOXI1	1.06e-03	1459	186	26	GO:0000977
GeneOntologyMolecularFunction	tau-protein kinase activity	TTBK1 MARK4 BRSK1	1.07e-03	22	186	3	GO:0050321
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	TCF12 ERG NTN3 GATA2 DACH1 PER1 RUNX1 KDM6B RFX7 ZNF467 E2F8 HIVEP3 HEYL HOXC5 SALL2 SALL1 WIZ ZNF358 ZNF197 PLAGL1 PAX2 FOXK1 FOXI1	1.30e-03	1244	186	23	GO:0000978
GeneOntologyMolecularFunction	histone modifying activity	KMT2B KDM6B SRCAP PRDM2 SETD2 SETBP1 KMT2A KAT14	1.41e-03	229	186	8	GO:0140993
GeneOntologyMolecularFunction	extracellular matrix structural constituent	MXRA5 COL27A1 ZP1 COL18A1 MUC2 MUC4 MUC6	1.94e-03	188	186	7	GO:0005201
GeneOntologyMolecularFunction	transcription coregulator binding	GATA2 PER1 RUNX1 WIZ PER3 VGLL4	2.02e-03	140	186	6	GO:0001221
GeneOntologyMolecularFunction	transcription coactivator activity	ASXL1 NACA MED14 SRCAP PPARGC1A TOX3 TOX2 MED13 PML	2.20e-03	303	186	9	GO:0003713
GeneOntologyMolecularFunction	protein serine kinase activity	RPS6KA2 CDC42BPB TTBK1 AATK MAST4 CDK13 CLK3 MARK4 ULK1 BRSK1	2.21e-03	363	186	10	GO:0106310
GeneOntologyMolecularFunction	transcription corepressor binding	PER1 RUNX1 WIZ PER3	2.23e-03	59	186	4	GO:0001222
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2B KMT2A	2.33e-03	8	186	2	GO:0140945
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	TCF12 ERG GATA2 TFDP3 RUNX1 ZNF467 PRDM2 HEYL SALL2 ZNF358 ZNF197 PLAGL1 FOXI1	2.34e-03	560	186	13	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	TCF12 ERG GATA2 TFDP3 RUNX1 ZNF467 PRDM2 HEYL SALL2 ZNF358 ZNF197 PLAGL1 FOXI1	2.56e-03	566	186	13	GO:0001216
GeneOntologyMolecularFunction	protein methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	2.79e-03	103	186	5	GO:0008276
GeneOntologyMolecularFunction	N-methyltransferase activity	KMT2B PRDM2 SETD2 SETBP1 KMT2A	3.03e-03	105	186	5	GO:0008170
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	HJV RPS6KA2 CDC42BPB TTBK1 AATK MAST4 CDK13 CLK3 MARK4 ULK1 BRSK1	3.17e-03	446	186	11	GO:0004674
GeneOntologyMolecularFunction	protein domain specific binding	TCF12 ZMYND8 GATA2 TFDP3 ARHGAP17 FAF1 CCDC88C HEYL ZNF106 WIZ ATXN2 CASKIN1 PKD1 PAX2 AP4M1 SRRM2 KAT14	3.43e-03	875	186	17	GO:0019904
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2B KMT2A	3.70e-03	10	186	2	GO:0140999
GeneOntologyMolecularFunction	unmethylated CpG binding	KMT2B KMT2A	3.70e-03	10	186	2	GO:0045322
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	HJV ZNF438 RALGAPA1 MAGEA2 ZNF703 MAGEA12 SAP25 PCGF2 RBM10 NACA ZMYND8 GATA2 DACH1 PER1 RRP8 RUNX1 KANK2 E2F8 PRDM2 SCAF4 HEYL NCOR2 AHRR SALL2 SALL1 TOB1 PER3 PIAS3 PLAGL1 PAX2 VGLL4 SPEN KAT14 FOXK1 PML	3.17e-08	1399	186	35	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	HJV ZNF438 RALGAPA1 MAGEA2 ZNF703 MAGEA12 SAP25 PCGF2 RBM10 NACA ZMYND8 GATA2 DACH1 PER1 RRP8 RUNX1 KANK2 E2F8 PRDM2 SCAF4 HEYL NCOR2 AHRR SALL2 SALL1 TOB1 PER3 PIAS3 PLAGL1 PAX2 VGLL4 SPEN KAT14 FOXK1 PML	4.05e-08	1413	186	35	GO:1902679
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	HJV ASXL1 TCF12 ERG BCAS3 NACA ZMYND8 GATA2 MED14 PER1 TFDP3 RUNX1 KDM6B RFX7 ZNF467 E2F8 PRDM2 PPARGC1A HEYL SALL2 SALL1 PTPRN CDK13 ZNF197 TOX3 PKD1 KMT2A PLAGL1 PAX2 TOX2 FUBP3 TOP2A MED13 FOXI1	8.87e-08	1390	186	34	GO:0045944
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	HJV RALGAPA1 MAGEA2 MAGEA12 PCGF2 RBM10 NACA ZMYND8 GATA2 DACH1 PER1 RUNX1 KANK2 E2F8 PRDM2 SCAF4 HEYL NCOR2 AHRR SALL2 SALL1 PER3 PIAS3 PLAGL1 PAX2 SPEN KAT14 FOXK1	2.73e-07	1053	186	28	GO:0000122
GeneOntologyBiologicalProcess	maintenance of gastrointestinal epithelium	ZNF830 MUC2 MUC4 MUC6	5.91e-05	24	186	4	GO:0030277
GeneOntologyBiologicalProcess	cell morphogenesis	ASXL1 MAP1A NUMBL MAP2 TPRN PPFIA2 COL27A1 NTN3 WASF3 GAS7 DSCAML1 KIAA0319 CCDC88C ARHGAP4 COL18A1 HEG1 ARHGEF40 ATXN2 FARP1 UNK PAX2 ULK1 ROBO3 BRSK1 NYAP1	7.45e-05	1194	186	25	GO:0000902
GeneOntologyBiologicalProcess	rhythmic process	AMH SERPINF1 PER1 RUNX1 PPARGC1A NCOR2 PER3 PTPRN KMT2A ZNF830 TOP2A PML	1.10e-04	360	186	12	GO:0048511
GeneOntologyBiologicalProcess	negative regulation of cell growth	SPHK2 MAP2 RBM10 KIAA0319 ARHGAP4 VGLL4 ULK1 FOXK1 PML	1.36e-04	212	186	9	GO:0030308
GeneOntologyBiologicalProcess	negative regulation of developmental growth	MAP2 RBM10 KIAA0319 ARHGAP4 ATXN2 VGLL4 ULK1	1.48e-04	126	186	7	GO:0048640
GeneOntologyBiologicalProcess	regulation of cell cycle	ZNF703 TICRR EP400 RPS6KA2 DACH1 TFDP3 PPP1R13B RRP8 NUP214 KANK2 E2F8 HEPACAM SETD2 TTBK1 CEP120 WIZ CDK13 MARK4 PKD1 PLAGL1 ZNF830 BRSK1 KAT14 FOXK1 PML	1.65e-04	1256	186	25	GO:0051726
GeneOntologyBiologicalProcess	ovulation cycle	AMH SERPINF1 RUNX1 NCOR2 PTPRN ZNF830	2.22e-04	95	186	6	GO:0042698
GeneOntologyBiologicalProcess	embryo development	PCGF2 TPRN COL27A1 GATA2 RUNX1 KDM6B DSCAML1 E2F8 COL18A1 NCOR2 SETD2 HEG1 HOXC5 SALL2 SALL1 ZNF358 KIAA1217 PKD1 KMT2A UNK ZNF830 PAX2 KAT14 CNOT3 TOP2A HTT FOXI1	2.26e-04	1437	186	27	GO:0009790
GeneOntologyBiologicalProcess	negative regulation of nuclear-transcribed mRNA poly(A) tail shortening	TENT4B TOB1	2.41e-04	3	186	2	GO:0060212
GeneOntologyBiologicalProcess	preantral ovarian follicle growth	AMH ZNF830	2.41e-04	3	186	2	GO:0001546
GeneOntologyBiologicalProcess	ureteric bud invasion	KIF26B SALL1	2.41e-04	3	186	2	GO:0072092
GeneOntologyBiologicalProcess	multi-layer follicle stage	AMH ZNF830	2.41e-04	3	186	2	GO:0048162
GeneOntologyBiologicalProcess	mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis	SALL1 PAX2	2.41e-04	3	186	2	GO:0072309
GeneOntologyBiologicalProcess	negative regulation of growth	SPHK2 MAP2 RBM10 KIAA0319 ARHGAP4 ATXN2 VGLL4 ULK1 FOXK1 PML	2.59e-04	283	186	10	GO:0045926
GeneOntologyBiologicalProcess	embryo development ending in birth or egg hatching	PCGF2 GATA2 RUNX1 DSCAML1 E2F8 NCOR2 SETD2 HEG1 HOXC5 SALL2 SALL1 ZNF358 KIAA1217 PKD1 UNK ZNF830 PAX2 CNOT3 HTT FOXI1	2.87e-04	929	186	20	GO:0009792
GeneOntologyBiologicalProcess	epithelial structure maintenance	ZNF830 MUC2 MUC4 MUC6	3.01e-04	36	186	4	GO:0010669
GeneOntologyBiologicalProcess	metanephric renal vesicle morphogenesis	KIF26B SALL1 PAX2	3.03e-04	15	186	3	GO:0072283
GeneOntologyBiologicalProcess	endothelial cell morphogenesis	COL27A1 COL18A1 HEG1	3.03e-04	15	186	3	GO:0001886
GeneOntologyBiologicalProcess	epithelium development	ZNF703 ASXL1 KIF26B TPRN COL27A1 GATA2 RUNX1 KDM6B KANK2 E2F8 CCDC88C COL18A1 HEYL NCOR2 SETD2 HEG1 SLC9A2 SALL2 SALL1 PNPLA1 ZNF358 PKD1 PAX2 BRSK1 MUC2 HTT PML	3.21e-04	1469	186	27	GO:0060429
GeneOntologyCellularComponent	nuclear body	MAGEA2 ATXN2L FAM193B MAGEA12 PCGF2 TCF12 EP400 RBM10 DACH1 PTPN23 SRCAP CHAMP1 PPARGC1A RGS14 NCOR2 ZNF106 PIAS3 CDK13 CLK3 SETBP1 PLAGL1 ZNF830 SRRM2 PML	1.87e-06	903	187	24	GO:0016604
GeneOntologyCellularComponent	primary dendrite	MAP1A MAP2	4.72e-04	4	187	2	GO:0150001
GeneOntologyCellularComponent	nuclear speck	ATXN2L FAM193B TCF12 EP400 RBM10 DACH1 ZNF106 PIAS3 CDK13 CLK3 ZNF830 SRRM2	5.26e-04	431	187	12	GO:0016607
GeneOntologyCellularComponent	dendritic shaft	CACNA1B MAP1A MAP2 ZMYND8 FUBP3	5.31e-04	74	187	5	GO:0043198
GeneOntologyCellularComponent	proximal neuron projection	MAP2 SYT5	7.82e-04	5	187	2	GO:1990769
GeneOntologyCellularComponent	nascent polypeptide-associated complex	NACA NACAD	7.82e-04	5	187	2	GO:0005854
HumanPheno	Periorbital fullness	PCGF2 KMT2B SRCAP SETD2 SPEN MED13	2.25e-05	45	67	6	HP:0000629
HumanPheno	Narrow palpebral fissure	PCGF2 SRCAP RFX7 CDC42BPB KMT2A SPEN MED13	3.39e-05	71	67	7	HP:0045025
HumanPheno	Recurrent maladaptive behavior	CACNA1B ASXL1 CLCA4 PCGF2 TCF12 KMT2B AVPR2 FGFRL1 MED13L RUNX1 KDM6B SRCAP RFX7 CHAMP1 CDC42BPB CHRNA4 MSTO1 SCAF4 PPARGC1A HEPACAM SETD2 ATXN2 CDK13 SETBP1 KMT2A FIP1L1 AP4M1 SRRM2 SPEN MED13 HTT PML	5.74e-05	1293	67	32	HP:5200241
HumanPheno	Generalized hypertrichosis	SRCAP SETBP1 KMT2A	7.33e-05	7	67	3	HP:0004554
HumanPheno	Abnormality of the hairline	RALGAPA1 ASXL1 TCF12 FGFRL1 MED13L SRCAP CDC42BPB FRMD4A SETD2 CDK13 KMT2A SPEN CNOT3	9.10e-05	294	67	13	HP:0009553
HumanPheno	Abnormal nasal tip morphology	PCGF2 KMT2B MED13L SRCAP RFX7 CDC42BPB SCAF4 COL18A1 SETD2 CDK13 SETBP1 KMT2A AP4M1 SRRM2 SPEN	1.06e-04	386	67	15	HP:0000436
HumanPheno	Abnormality of the scalp hair	RALGAPA1 ASXL1 PCGF2 TCF12 FGFRL1 MED13L SRCAP KANK2 CDC42BPB FRMD4A COL18A1 SETD2 CDK13 KMT2A SPEN CNOT3	1.09e-04	433	67	16	HP:0100037
HumanPheno	Long face	ASXL1 PCGF2 KMT2B BCAS3 SRCAP CHAMP1 CDC42BPB MSTO1 SETD2 CEP120 SETBP1 SPEN	1.13e-04	259	67	12	HP:0000276
HumanPheno	Macrostomia	RALGAPA1 KMT2B MED13L KDM6B SRCAP CDC42BPB SALL1 SETBP1 AP4M1 SPEN MED13	1.15e-04	220	67	11	HP:0000181
HumanPheno	Wide mouth	RALGAPA1 KMT2B MED13L KDM6B SRCAP CDC42BPB SALL1 SETBP1 AP4M1 SPEN MED13	1.15e-04	220	67	11	HP:0000154
HumanPheno	Satyr ear	PCGF2 SALL1	1.70e-04	2	67	2	HP:0030676
HumanPheno	Abnormal scalp morphology	RALGAPA1 ASXL1 PCGF2 TCF12 FGFRL1 MED13L SRCAP KANK2 CDC42BPB FRMD4A COL18A1 SETD2 CDK13 KMT2A SPEN CNOT3	1.71e-04	450	67	16	HP:0001965
HumanPheno	Bulbous nose	KMT2B MED13L SRCAP SCAF4 COL18A1 CDK13 KMT2A AP4M1 SRRM2 SPEN	2.54e-04	201	67	10	HP:0000414
HumanPheno	Large face	ASXL1 PCGF2 KMT2B BCAS3 SRCAP CHAMP1 CDC42BPB MSTO1 SETD2 CEP120 SETBP1 SPEN	2.62e-04	283	67	12	HP:0100729
HumanPheno	Congenital abnormal hair pattern	RALGAPA1 ASXL1 TCF12 FGFRL1 MED13L SRCAP CDC42BPB FRMD4A SETD2 CDK13 KMT2A SPEN CNOT3	2.66e-04	327	67	13	HP:0011361
HumanPheno	Autistic behavior	CACNA1B PCGF2 TCF12 KMT2B MED13L KDM6B SRCAP RFX7 CDC42BPB MSTO1 SCAF4 HEPACAM SETD2 CDK13 SETBP1 KMT2A SRRM2 SPEN CNOT3 MED13	2.90e-04	678	67	20	HP:0000729
MousePheno	abnormal pre-Botzinger complex physiology	KDM6B DBX1 ROBO3	2.56e-05	6	154	3	MP:0010746
MousePheno	pericardial effusion	KMT2B ERG NACA RUNX1 SETD2 HEG1 CDK13 PKD1	3.06e-05	111	154	8	MP:0005312
MousePheno	effusion	KMT2B ERG NACA MUC5B RUNX1 SETD2 HEG1 CDK13 PKD1	4.64e-05	152	154	9	MP:0021205
Domain	VWF_type-D	MUC5B MUC2 MUC4 MUC6 OTOG	3.91e-07	16	188	5	IPR001846
Domain	VWFD	MUC5B MUC2 MUC4 MUC6 OTOG	3.91e-07	16	188	5	PS51233
Domain	VWD	MUC5B MUC2 MUC4 MUC6 OTOG	3.91e-07	16	188	5	SM00216
Domain	VWD	MUC5B MUC2 MUC4 MUC6 OTOG	3.91e-07	16	188	5	PF00094
Domain	C8	MUC5B MUC2 MUC6 OTOG	4.62e-06	12	188	4	PF08742
Domain	TIL	MUC5B MUC2 MUC6 OTOG	4.62e-06	12	188	4	PF01826
Domain	Unchr_dom_Cys-rich	MUC5B MUC2 MUC6 OTOG	6.62e-06	13	188	4	IPR014853
Domain	C8	MUC5B MUC2 MUC6 OTOG	6.62e-06	13	188	4	SM00832
Domain	TIL_dom	MUC5B MUC2 MUC6 OTOG	9.20e-06	14	188	4	IPR002919
Domain	VWC_out	MUC5B MUC2 MUC6 OTOG	3.42e-05	19	188	4	SM00215
Domain	CT	MUC5B MUC2 MUC6 OTOG	6.31e-05	22	188	4	SM00041
Domain	SM_dom_ATX	ATXN2L ATXN2	1.01e-04	2	188	2	IPR025852
Domain	Med13_N	MED13L MED13	1.01e-04	2	188	2	PF11597
Domain	Mediator_Med13_N_met/fun	MED13L MED13	1.01e-04	2	188	2	IPR021643
Domain	LsmAD	ATXN2L ATXN2	1.01e-04	2	188	2	PF06741
Domain	LsmAD_domain	ATXN2L ATXN2	1.01e-04	2	188	2	IPR009604
Domain	MeTrfase_trithorax	KMT2B KMT2A	1.01e-04	2	188	2	IPR016569
Domain	LsmAD	ATXN2L ATXN2	1.01e-04	2	188	2	SM01272
Domain	Med13_C	MED13L MED13	1.01e-04	2	188	2	PF06333
Domain	Mediator_Med13	MED13L MED13	1.01e-04	2	188	2	IPR009401
Domain	SM-ATX	ATXN2L ATXN2	1.01e-04	2	188	2	PF14438
Domain	Cys_knot_C	MUC5B MUC2 MUC6 OTOG	1.07e-04	25	188	4	IPR006207
Domain	CTCK_2	MUC5B MUC2 MUC6 OTOG	1.07e-04	25	188	4	PS01225
Domain	AT_hook	KMT2B SRCAP SETBP1 KMT2A	1.46e-04	27	188	4	SM00384
Domain	AT_hook_DNA-bd_motif	KMT2B SRCAP SETBP1 KMT2A	1.46e-04	27	188	4	IPR017956
Domain	Period_circadian-like_C	PER1 PER3	3.00e-04	3	188	2	IPR022728
Domain	Period_C	PER1 PER3	3.00e-04	3	188	2	PF12114
Domain	EGD2/NACA	NACA NACAD	3.00e-04	3	188	2	IPR016641
Domain	Post-SET_dom	KMT2B SETD2 KMT2A	5.10e-04	16	188	3	IPR003616
Domain	PostSET	KMT2B SETD2 KMT2A	5.10e-04	16	188	3	SM00508
Domain	POST_SET	KMT2B SETD2 KMT2A	5.10e-04	16	188	3	PS50868
Domain	HSA	EP400 SRCAP	5.97e-04	4	188	2	SM00573
Domain	HSA	EP400 SRCAP	5.97e-04	4	188	2	PS51204
Domain	HSA_dom	EP400 SRCAP	5.97e-04	4	188	2	IPR014012
Domain	HSA	EP400 SRCAP	5.97e-04	4	188	2	PF07529
Domain	SET	KMT2B PRDM2 SETD2 KMT2A	7.53e-04	41	188	4	PF00856
Domain	VWF_dom	MUC5B MUC2 MUC6 OTOG	8.25e-04	42	188	4	IPR001007
Domain	FYrich_C	KMT2B KMT2A	9.88e-04	5	188	2	IPR003889
Domain	FYrich_N	KMT2B KMT2A	9.88e-04	5	188	2	IPR003888
Domain	NAC	NACA NACAD	9.88e-04	5	188	2	SM01407
Domain	FYRC	KMT2B KMT2A	9.88e-04	5	188	2	SM00542
Domain	FYRN	KMT2B KMT2A	9.88e-04	5	188	2	SM00541
Domain	FYRN	KMT2B KMT2A	9.88e-04	5	188	2	PF05964
Domain	FYRC	KMT2B KMT2A	9.88e-04	5	188	2	PF05965
Domain	FYRC	KMT2B KMT2A	9.88e-04	5	188	2	PS51543
Domain	FYRN	KMT2B KMT2A	9.88e-04	5	188	2	PS51542
Domain	SET	KMT2B PRDM2 SETD2 KMT2A	1.17e-03	46	188	4	SM00317
Domain	Nas_poly-pep-assoc_cplx_dom	NACA NACAD	1.47e-03	6	188	2	IPR002715
Domain	NAC	NACA NACAD	1.47e-03	6	188	2	PF01849
Domain	PKD/REJ-like	KIAA0319 PKD1	1.47e-03	6	188	2	IPR002859
Domain	NAC_AB	NACA NACAD	1.47e-03	6	188	2	PS51151
Domain	REJ	KIAA0319 PKD1	1.47e-03	6	188	2	PF02010
Domain	Liprin	PPFIA2 PPFIA3	1.47e-03	6	188	2	IPR029515
Domain	WxxW_domain	MUC5B MUC2	1.47e-03	6	188	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC2	1.47e-03	6	188	2	PF13330
Domain	TSPN	COL20A1 COL27A1 COL18A1	1.53e-03	23	188	3	SM00210
Domain	SET_dom	KMT2B PRDM2 SETD2 KMT2A	1.60e-03	50	188	4	IPR001214
Domain	SET	KMT2B PRDM2 SETD2 KMT2A	1.60e-03	50	188	4	PS50280
Domain	tRNA-bd_arm	PPFIA2 PPFIA3 CNOT3	1.74e-03	24	188	3	IPR010978
Domain	ZINC_FINGER_C2H2_2	ZNF438 ZNF703 RBM10 ZNF619 ZNF467 CHAMP1 PRDM2 HIVEP3 ZNF106 SALL2 SALL1 WIZ ZNF358 ZNF197 PLAGL1 ZNF830 ZNF598	2.19e-03	775	188	17	PS50157
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC5B MUC12 MUC4 MUC6	1.42e-05	16	137	4	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC5B MUC12 MUC4 MUC6	1.84e-05	17	137	4	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC2 MUC4 MUC6	4.49e-05	21	137	4	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC5B MUC12 MUC4 MUC6	6.55e-05	23	137	4	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC5B MUC12 MUC4 MUC6	1.08e-04	26	137	4	M27483
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	MED14 MED13L ZNF467 PPARGC1A NCOR2 MED13	1.65e-04	84	137	6	M1008
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FAM193B SPHK2 KMT2B EP400 BCAS3 RPS6KA2 FBRS GATA2 MED14 PER1 FGFRL1 ARHGAP17 NUP214 MED13L KDM6B SRCAP ANKHD1 CDC42BPB HIVEP3 CCDC88C HEYL NCOR2 HEG1 ARHGEF40 AATK WIZ ADAMTS7 CDK13 CASKIN1 MARK4 PKD1 SEC16A RIPOR1 PAX2 ULK1 SPEN MYRF MED13 FOXK1 HTT BAHCC1	1.23e-22	1105	189	41	35748872
Pubmed	Human transcription factor protein interaction networks.	ZNF703 ASXL1 TCF12 KMT2B ERG EP400 RBM10 NACA ZMYND8 FBRS GATA2 DACH1 PPP1R13B PROSER1 NUP214 SRCAP RFX7 ANKHD1 PRDM2 SCAF4 NCOR2 SALL2 SALL1 WIZ ATXN2 SEC16A KMT2A FIP1L1 UNK PAX2 VGLL4 SRRM2 SPEN FUBP3 KAT14 CNOT3 FOXK1 FOXI1 PML	5.83e-17	1429	189	39	35140242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L KMT2B ERG EP400 RBM10 ZMYND8 MED14 NUP214 RUNX1 RFX7 CHAMP1 PRDM2 SCAF4 NCOR2 ZNF106 SETD2 CDK13 SEC16A KMT2A FIP1L1 UNK RIPOR1 SRRM2 SPEN CNOT3 TOP2A MED13	1.96e-14	774	189	27	15302935
Pubmed	Interaction network of human early embryonic transcription factors.	ZNF703 KMT2B EP400 FBRS PROSER1 NUP214 RFX7 PRDM2 NCOR2 SALL1 WIZ SEC16A KMT2A SPEN KAT14 TOP2A FOXK1 BAHCC1	1.03e-12	351	189	18	38297188
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L ZNF703 EP400 MAP1A TPRN FBRS PPP1R13B ARHGAP17 ZCCHC2 SRCAP NCOR2 SETD2 SALL2 SALL1 KIAA1217 SEC16A UNK SPEN KAT14 CNOT3 FOXK1 PML	1.54e-12	588	189	22	38580884
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TCF12 EP400 MAP1A TPRN ZMYND8 FBRS PER1 GAS7 PPFIA3 SRCAP ANKHD1 CHAMP1 KANK2 ARHGAP4 NCOR2 SETD2 ARHGEF40 SALL2 WIZ FAM120C MARK4 SEC16A FIP1L1 SRRM2 KAT14 TOP2A FOXK1 PML BAHCC1	3.06e-12	1116	189	29	31753913
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 ATXN2L NUMBL MAP2 KIF26B BCAS3 RPS6KA2 ARHGAP17 RFX7 E2F8 CCDC88C ZNF106 MAST4 CLK3 STARD9 KIAA1217 MARK4 SEC16A KMT2A FIP1L1 ZNF598 SRRM2 FOXK1 OTOG PML	1.07e-11	861	189	25	36931259
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ATXN2L KMT2B EP400 RBM10 MED14 DACH1 PPP1R13B PTPN23 SRCAP ANKHD1 CHAMP1 SCAF4 SETD2 WIZ SEC16A KMT2A ZNF598 SPEN TOP2A HTT	2.72e-11	549	189	20	38280479
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	KMT2B ZMYND8 FBRS TFDP3 NUP214 RBBP8NL ANKHD1 CHAMP1 MSTO1 PRDM2 NCOR2 SALL2 SALL1 WIZ SEC16A KAT14 GOLGA3	1.68e-10	418	189	17	34709266
Pubmed	A census of human transcription factors: function, expression and evolution.	TCF12 ERG GATA2 TFDP3 RUNX1 RFX7 E2F8 PRDM2 HIVEP3 HEYL HOXC5 SALL2 SALL1 DBX1 SETBP1 ZNF197 TOX3 KMT2A PLAGL1 PAX2 TOX2 MYRF FOXK1 FOXI1	1.92e-10	908	189	24	19274049
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ATXN2L FAM193B EP400 MAP1A NUMBL RBM10 NACA ZMYND8 PTPN23 NUP214 SRCAP ANKHD1 CHAMP1 RTN1 SCAF4 SETD2 WIZ KIAA1217 SEC16A KMT2A ZNF598 TOP2A PML	1.83e-09	934	189	23	33916271
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L TCF12 KMT2B EP400 RBM10 ZMYND8 MED14 DACH1 MED13L RUNX1 E2F8 PRDM2 SCAF4 NCOR2 WIZ ATXN2 CDK13 KMT2A FIP1L1 SRRM2 SPEN FUBP3 TOP2A FOXK1 PML	1.83e-09	1103	189	25	34189442
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FAM193B COL27A1 PER1 GAS7 PTPN23 ZCCHC2 CDC42BPB SCAF4 HIVEP3 CCDC88C SETD2 KRBA1 AHRR TTBK1 PER3 CDK13 CNOT3	2.05e-09	493	189	17	15368895
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SPATA31E1 EP400 MAP1A ZMYND8 NUP214 NCOR2 AATK SALL1 TOB1 PIAS3 ATXN2 SETBP1 UNK NYAP1 SPEN FOXI1	2.12e-09	430	189	16	35044719
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TICRR KMT2B EP400 RBM10 ZMYND8 GATA2 RRP8 NUP214 RUNX1 SRCAP RFX7 CHAMP1 PRDM2 SCAF4 NCOR2 ZNF106 SETD2 WIZ CDK13 KMT2A FIP1L1 SRRM2 SPEN FUBP3 KAT14 TOP2A FOXK1	2.29e-09	1294	189	27	30804502
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ATXN2L EP400 RBM10 ZMYND8 DACH1 RRP8 NUP214 CHAMP1 SCAF4 NCOR2 SETD2 SALL1 WIZ ATXN2 SEC16A KMT2A FIP1L1 ZNF830 SRRM2 SPEN FUBP3 TOP2A PML	2.73e-09	954	189	23	36373674
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	ASXL1 WASF3 PTPN23 PPFIA3 MED13L CDC42BPB DSCAML1 AATK SALL2 NRXN2 SETBP1 SEC16A	4.45e-09	225	189	12	12168954
Pubmed	MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.	ERG GATA2 MED13L RUNX1 MED13	5.58e-09	13	189	5	27570068
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	KMT2B KDM6B SRCAP NACAD KIAA0319 SALL2 MAST4 SEC16A SRRM2	6.01e-09	104	189	9	9205841
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ATXN2L EP400 RBM10 ZMYND8 MED14 SRCAP CHAMP1 WIZ FAM120C KMT2A FIP1L1 SRRM2 SPEN FOXK1	6.46e-09	341	189	14	32971831
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	TENT4B KMT2B EP400 NUMBL NACA ZMYND8 MED14 WHAMM RRP8 ANKHD1 KANK2 CDC42BPB SCAF4 COL18A1 SETD2 WIZ ATXN2 FAM120C CDK13 CLK3 FARP1 KMT2A UNK ZNF598 SPEN CNOT3 MED13 FOXK1	1.20e-08	1497	189	28	31527615
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF438 TCF12 RBM10 ZMYND8 GATA2 TFDP3 SRCAP HIVEP3 KRBA1 SALL1 WIZ PER3 PIAS3 TOX3 UNK ZNF830 PAX2 ZNF598 FOXK1 PML	2.06e-08	808	189	20	20412781
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TCF12 EP400 MAP1A NUMBL DACH1 SYNPO NCOR2 ZNF106 SALL2 SALL1 PIAS3 SEC16A TOP2A FOXK1 PML	2.48e-08	444	189	15	34795231
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC5B MUC12 MUC2 MUC4 MUC6	3.64e-08	18	189	5	18834073
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	ASXL1 TCF12 EP400 BCAS3 ZMYND8 DACH1 PER1 ANKHD1 KANK2 NCOR2 SALL2 SALL1 WIZ FIP1L1 ZNF598 SPEN FUBP3 TOP2A FOXK1 FOXI1	5.39e-08	857	189	20	25609649
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	EP400 COL27A1 CHAMP1 KRBA1 TTBK1 CDK13 MARK4 BRSK1	1.35e-07	107	189	8	11347906
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	EP400 NUMBL NCOR2 ATXN2 TOX3	1.40e-07	23	189	5	9225980
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PCGF2 ERG ZMYND8 WHAMM GAS7 SYNPO ZNF619 MED13L RUNX1 KDM6B SEC31B KANK2 CDC42BPB DSCAML1 MSTO1 FAF1 WIZ PIAS3 ZNF197 PKD1 FIP1L1 CNOT3 MED13 GOLGA3	1.51e-07	1285	189	24	35914814
Pubmed	Secretory carcinoma of breast: pattern of MUC 2/MUC 4/MUC 6 expression.	MUC2 MUC4 MUC6	1.58e-07	3	189	3	23305535
Pubmed	Identification of functional cooperative mutations of SETD2 in human acute leukemia.	RUNX1 SETD2 KMT2A	1.58e-07	3	189	3	24509477
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	RALGAPA1 EP400 NACA SYNPO KDM6B ANKHD1 CHAMP1 NACAD ARHGAP4 MAST4 NRXN2 CASKIN1 SETBP1 UNK MED13	2.38e-07	529	189	15	14621295
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	EP400 RBM10 ZMYND8 FBRS MED14 MED13L CHAMP1 WIZ KMT2A MED13 FOXK1	2.83e-07	268	189	11	33640491
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	EP400 MED14 MED13L CHAMP1 SALL2 SALL1 WIZ MED13 PML	3.65e-07	167	189	9	20362541
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	PCGF2 TCF12 ERG ZMYND8 GATA2 TFDP3 ZNF467 CHAMP1 HEYL AHRR HOXC5 SALL2 PIAS3 ZNF358 KMT2A PAX2 FOXK1	3.89e-07	709	189	17	22988430
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ZNF703 KMT2B EP400 FBRS TFDP3 CHAMP1 SCAF4 SALL2 KMT2A FIP1L1 SPEN PML	3.94e-07	339	189	12	30415952
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ASXL1 EP400 RBM10 NUP214 MED13L KIAA0319 STARD9 MARK4 SEC16A RIPOR1 ULK1 SRRM2 SPEN	4.12e-07	407	189	13	12693553
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1B ATXN2L MAP1A NUMBL MAP2 BCAS3 PPFIA2 SYNPO RTN1 CASKIN1 SRRM2 HTT	5.05e-07	347	189	12	17114649
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 NUMBL MAP2 BCAS3 PPFIA2 RPS6KA2 WASF3 FGFRL1 SYNPO RBBP8NL CDC42BPB FAF1 HIVEP3 COL18A1 NCOR2 ATXN2 FAM120C CDK13 FARP1 KIAA1217 SETBP1 TOX3 RIPOR1 VGLL4 HTT	5.91e-07	1489	189	25	28611215
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	23807779
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	17471237
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	29869461
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	21596555
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC2 MUC6	6.29e-07	4	189	3	12676567
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	KMT2B EP400 RBM10 ZMYND8 WIZ KMT2A FIP1L1 SPEN	7.62e-07	134	189	8	25452129
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ATXN2L EP400 RBM10 FBRS MED14 RRP8 NUP214 SRCAP SETD2 SEC16A FIP1L1 TOP2A PML	9.85e-07	440	189	13	34244565
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	KMT2B RBM10 CHAMP1 CDC42BPB SCAF4 CLK3 KMT2A FIP1L1 SPEN TOP2A	1.30e-06	251	189	10	31076518
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ATXN2L FAM193B KMT2B NUMBL RBM10 ZMYND8 GAS7 TNS2 ANKHD1 SETD2 PTPRN ATXN2 UNK SPEN FUBP3	1.36e-06	608	189	15	16713569
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NUMBL RPS6KA2 SYNPO PPFIA3 KANK2 CDC42BPB RTN1 KIAA0319 CCDC88C NCOR2 WIZ ATXN2 FAM120C FARP1 KIAA1217 CASKIN1 SEC16A BRSK1 GOLGA3	1.47e-06	963	189	19	28671696
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC2 MUC4	1.57e-06	5	189	3	11062147
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC2 MUC4 MUC6	1.57e-06	5	189	3	16475027
Pubmed	Comprehensive glycomics comparison between colon cancer cell cultures and tumours: implications for biomarker studies.	MUC5B MUC2 MUC6	1.57e-06	5	189	3	24840470
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	PCGF2 TCF12 ERG GATA2 DACH1 PER1 ZNF467 E2F8 PPARGC1A HEYL NCOR2 HOXC5 PIAS3 TOX3 SPEN FUBP3 CNOT3 PML	1.63e-06	877	189	18	20211142
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	EPS8L2 EP400 MAP1A NACA ZMYND8 PTPN23 CHAMP1 KANK2 SCAF4 SEC16A SRRM2 FUBP3 PML	2.14e-06	472	189	13	38943005
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	FAM193B MAP1A KIF26B KANK2 RTN1 MAST4 SEC16A UNK GOLGA3	2.36e-06	209	189	9	36779422
Pubmed	Roles of tau protein in health and disease.	MAP1A MAP2 TTBK1 MARK4 BRSK1	2.53e-06	40	189	5	28386764
Pubmed	Genomic analysis of mouse retinal development.	TCF12 KMT2B MAP2 TFDP3 FGFRL1 NPDC1 RTN1 NCOR2 SALL2 PIAS3 NRXN2 PKD1 KMT2A UNK ULK1 ROBO3 TOX2 FOXK1 UBALD1	2.78e-06	1006	189	19	15226823
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC5B MUC2 MUC6	3.12e-06	6	189	3	19110483
Pubmed	[Role of molecular screening for common fusion genes in the diagnosis and classification of leukemia].	RUNX1 KMT2A PML	3.12e-06	6	189	3	15968309
Pubmed	Zinc finger protein sall2 is not essential for embryonic and kidney development.	SALL2 SALL1 PAX2	3.12e-06	6	189	3	12482961
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	TCF12 EP400 RBM10 NACA NUP214 ANKHD1 CHAMP1 SALL2 SALL1 WIZ PML	4.61e-06	357	189	11	37059091
Pubmed	Analysis of FGF20-regulated genes in organ of Corti progenitors by translating ribosome affinity purification.	GATA2 HEYL SALL2 SALL1	4.70e-06	21	189	4	32492250
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	ERG NACA ARHGAP17 ANKHD1 CDC42BPB SCAF4 KIAA1217 SEC16A SRRM2 GOLGA3 PML	4.99e-06	360	189	11	33111431
Pubmed	Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation.	AMH SYNPO PAX2	5.44e-06	7	189	3	11509181
Pubmed	Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia.	ERG GATA2 RUNX1	5.44e-06	7	189	3	23327922
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	EP400 DACH1 NCOR2 WIZ SPEN FOXK1	6.34e-06	83	189	6	28794006
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	ZNF703 RBM10 DCBLD1 RFX7 NCOR2 SEC16A FIP1L1 FUBP3	6.90e-06	180	189	8	35198878
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	TCF12 EP400 RBM10 MED14 MED13L RUNX1 CHAMP1 ZNF106 SETD2 PIAS3 MED13 PML	7.86e-06	453	189	12	29656893
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KMT2B ZMYND8 DSCAML1 FRMD4A AATK SALL2	8.34e-06	87	189	6	12465718
Pubmed	The mutational landscape of lethal castration-resistant prostate cancer.	ASXL1 ERG KMT2A	8.67e-06	8	189	3	22722839
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	ATXN2L TENT4B RRP8 ANKHD1 SCAF4 ATXN2 FAM120C CDK13 CLK3 FIP1L1 UNK ZNF598 SRRM2 SPEN FUBP3 TOP2A	9.70e-06	807	189	16	22681889
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ATXN2L ZNF703 MAP1A BCAS3 ANKHD1 CDC42BPB WIZ ATXN2 FAM120C FARP1 FIP1L1 UNK ZNF598 SPEN FUBP3	1.11e-05	724	189	15	36232890
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 ATXN2L MAP1A NUMBL MAP2 BCAS3 PPFIA2 SYNPO PPFIA3 KANK2 CDC42BPB RTN1 GJA3 NRXN2 FAM120C FARP1 KIAA1217 CASKIN1 SEC16A KMT2A BRSK1 GOLGA3	1.19e-05	1431	189	22	37142655
Pubmed	Laser capture microdissection and cDNA array analysis for identification of mouse KIAA/FLJ genes differentially expressed in the embryonic dorsal spinal cord.	NUP214 PPFIA3 KIAA0319 ZNF598	1.34e-05	27	189	4	19026994
Pubmed	New nomenclature for chromatin-modifying enzymes.	KMT2B KDM6B PRDM2 SETD2 KMT2A	1.50e-05	57	189	5	18022353
Pubmed	A human MAP kinase interactome.	MAP1A KIF26B PPP1R13B ARHGAP17 GAS7 PTPN23 SYNPO NUP214 MUC12 CDC42BPB ZNF106 PIAS3	1.58e-05	486	189	12	20936779
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1B ATXN2L MAP1A MAP2 BCAS3 PPFIA2 NACA PER1 SYNPO PPFIA3 CDC42BPB RTN1 NACAD FRMD4A FAM120C FARP1 KIAA1217 CASKIN1 CNOT3	1.60e-05	1139	189	19	36417873
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	TCF12 EP400 PROSER1 NCOR2 SALL2 SALL1 CEP120 WIZ KMT2A SRRM2 TOP2A	1.72e-05	411	189	11	35182466
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	EP400 RBM10 NACA MED14 PTPN23 NUP214 PPFIA3 KANK2 NCOR2 SETD2 SLC9A2 WIZ SEC16A RIPOR1 GOLGA3	1.78e-05	754	189	15	35906200
Pubmed	HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia.	MED14 MED13L MED13	1.84e-05	10	189	3	23746844
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	ATXN2L NUP214 ATXN2 FARP1 SEC16A FUBP3	1.96e-05	101	189	6	26949739
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	CACNA1B COL27A1 NACA PRDM2 CCDC88C KMT2A SPEN OTOG	1.97e-05	208	189	8	33230847
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TCF12 RUNX1 NCOR2 SPEN	2.07e-05	30	189	4	26593974
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	ATXN2L ZNF703 TPRN FBRS PROSER1 RFX7 NCOR2	2.08e-05	152	189	7	38360978
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	ZMYND8 CHAMP1 WIZ KMT2A SPEN TOP2A	2.20e-05	103	189	6	32744500
Pubmed	Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	EP400 COL20A1 PTPN23 KANK2 CCDC88C BAHCC1	2.20e-05	103	189	6	10819331
Pubmed	Functional proteomics mapping of a human signaling pathway.	KMT2B TPRN ZMYND8 PPP1R13B FAF1 HEYL NCOR2 ZNF106 MAST4 PIAS3 CDK13 PKD1 PLAGL1	2.35e-05	591	189	13	15231748
Pubmed	Cloning of the genes encoding two murine and human cochlear unconventional type I myosins.	MAST4 ATXN2 SPEN	2.52e-05	11	189	3	9119401
Pubmed	Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear.	SALL1 PAX2 FOXI1	2.52e-05	11	189	3	16916509
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	SPHK2 EP400 MAP2 ZMYND8 MED14 SRCAP CHAMP1 WIZ KMT2A	2.54e-05	281	189	9	24163370
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	TCF12 EP400 ZMYND8 NUP214 RUNX1 SETD2 SEC16A SPEN CNOT3	2.61e-05	282	189	9	23667531
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	EP400 RBM10 ZMYND8 DACH1 CHAMP1 WIZ ZNF830 SPEN TOP2A	2.69e-05	283	189	9	30585729
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	PPFIA2 PPP1R13B PPFIA3 CEP120 UNK ZC3H12C ZNF598 NYAP1	2.76e-05	218	189	8	33378226
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	EP400 MAP1A NUMBL MAP2 RBM10 ZMYND8 MED14 SRCAP CHAMP1 SCAF4 SETD2 WIZ NRXN2 CLK3 FARP1 FIP1L1 SRRM2 SPEN	2.80e-05	1082	189	18	38697112
Pubmed	Spatial Chromosome Folding and Active Transcription Drive DNA Fragility and Formation of Oncogenic MLL Translocations.	KMT2A TOP2A	2.94e-05	2	189	2	31202576
Pubmed	Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors.	GAS7 KMT2A	2.94e-05	2	189	2	10706619
Pubmed	Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity.	RUNX1 NCOR2	2.94e-05	2	189	2	17560331
Pubmed	Loss of SETD2 Induces a Metabolic Switch in Renal Cell Carcinoma Cell Lines toward Enhanced Oxidative Phosphorylation.	PPARGC1A SETD2	2.94e-05	2	189	2	30406665
Pubmed	N-type Ca2+ channels are affected by full-length mutant huntingtin expression in a mouse model of Huntington's disease.	CACNA1B HTT	2.94e-05	2	189	2	28391067
Pubmed	Autoinhibitory structure of the WW domain of HYPB/SETD2 regulates its interaction with the proline-rich region of huntingtin.	SETD2 HTT	2.94e-05	2	189	2	24412394
Interaction	TOP3B interactions	FAM193B SPHK2 KMT2B EP400 BCAS3 RPS6KA2 FBRS GATA2 MED14 PER1 FGFRL1 ARHGAP17 NUP214 MED13L KDM6B SRCAP ANKHD1 KANK2 CDC42BPB HIVEP3 CCDC88C HEYL NCOR2 HEG1 ARHGEF40 AATK WIZ ADAMTS7 ATXN2 FAM120C CDK13 CASKIN1 MARK4 PKD1 SEC16A UNK RIPOR1 PAX2 ULK1 ZNF598 SPEN MYRF FUBP3 MED13 FOXK1 HTT BAHCC1	4.92e-14	1470	189	47	int:TOP3B
Interaction	KDM6A interactions	ASXL1 KMT2B ERG GATA2 PROSER1 KMT2A PAX2 KAT14 FOXK1 HTT FOXI1	3.85e-07	162	189	11	int:KDM6A
Interaction	TLE3 interactions	ZNF703 TCF12 ERG FBRS GATA2 PROSER1 RUNX1 SCAF4 NCOR2 SETD2 SALL1 KMT2A PAX2 SRRM2 SPEN FOXI1	5.52e-07	376	189	16	int:TLE3
Interaction	FHL2 interactions	ATXN2L EP400 RUNX1 KANK2 NCOR2 ZNF106 TOB1 KIAA1217 TOX3 SPEN KAT14 CNOT3 FOXK1 HTT PML BAHCC1	1.09e-06	396	189	16	int:FHL2
Interaction	YWHAG interactions	RALGAPA1 ATXN2L TICRR NUMBL MAP2 KIF26B BCAS3 ARHGAP17 TNS2 SYNPO RFX7 E2F8 FAF1 CCDC88C FRMD4A ZNF106 TTBK1 MAST4 CLK3 STARD9 MARK4 SEC16A KMT2A FIP1L1 UNK ULK1 SRRM2 FOXK1 HTT OTOG	1.86e-06	1248	189	30	int:YWHAG
Interaction	ZNF608 interactions	KMT2B ERG GATA2 KMT2A PAX2 KAT14 FOXI1 PML	2.66e-06	93	189	8	int:ZNF608
Interaction	SOX2 interactions	ATXN2L PCGF2 TCF12 ERG EP400 MAP1A SERPINF1 ZMYND8 FBRS DACH1 PROSER1 NUP214 MED13L RUNX1 ANKHD1 CHAMP1 FRMD4A NCOR2 SETD2 ARHGEF40 SALL2 SALL1 WIZ KIAA1217 SEC16A KMT2A FIP1L1 BRSK1 SPEN FUBP3 CNOT3 FOXK1	3.28e-06	1422	189	32	int:SOX2
Interaction	YTHDF3 interactions	ZCCHC2 ANKHD1 FAF1 ATXN2 IFITM3 FAM120C UNK ZNF598 FUBP3 CNOT3 TOP2A PML	3.78e-06	246	189	12	int:YTHDF3
Interaction	CREBBP interactions	TCF12 ERG RPS6KA2 GATA2 DACH1 RUNX1 KDM6B SRCAP FAF1 PPARGC1A NCOR2 ZNF106 PIAS3 KMT2A PLAGL1 CNOT3 HTT FOXI1 PML	3.85e-06	599	189	19	int:CREBBP
Interaction	YWHAH interactions	RALGAPA1 ATXN2L TICRR NUMBL MAP2 KIF26B BCAS3 ARHGAP17 TNS2 RFX7 CHRNA4 E2F8 FAF1 CCDC88C FRMD4A ZNF106 MAST4 CLK3 STARD9 KIAA1217 MARK4 SEC16A KMT2A SRRM2 FOXK1 HTT OTOG	4.59e-06	1102	189	27	int:YWHAH
Interaction	TERF2IP interactions	KMT2B EP400 ZMYND8 DACH1 SRCAP CHAMP1 NCOR2 SETD2 SALL2 WIZ CDK13 KMT2A ZNF830 VGLL4 SRRM2 SPEN TOP2A PML	4.80e-06	552	189	18	int:TERF2IP
Interaction	RFPL4B interactions	PER1 KRBA1 SALL2 SALL1 KAT14 PML	5.56e-06	48	189	6	int:RFPL4B
Interaction	YWHAE interactions	RALGAPA1 ATXN2L TICRR NUMBL KIF26B RBM10 WASF3 TNS2 KANK2 E2F8 FAF1 CCDC88C FRMD4A NCOR2 ZNF106 MAST4 CDK13 MARK4 KMT2A UNK ULK1 BRSK1 ZNF598 SRRM2 TOP2A GOLGA3 FOXK1 HTT OTOG	6.19e-06	1256	189	29	int:YWHAE
Interaction	NFIX interactions	KMT2B EP400 DACH1 SRCAP NCOR2 SALL1 WIZ KMT2A PAX2 SPEN KAT14	1.03e-05	227	189	11	int:NFIX
Interaction	SMG7 interactions	ZNF703 RBM10 DACH1 NCOR2 ZNF106 SALL2 SALL1 ATXN2 FAM120C SEC16A UNK FUBP3 CNOT3	1.05e-05	319	189	13	int:SMG7
Interaction	WWTR1 interactions	ATXN2L EP400 RBM10 PPP1R13B PTPN23 RUNX1 SRCAP ANKHD1 SETD2 WIZ SEC16A KMT2A ZNF598 TOP2A HTT	1.12e-05	422	189	15	int:WWTR1
Interaction	CNOT9 interactions	ANKHD1 AATK SALL1 TOB1 ATXN2 FAM120C SEC16A UNK ZNF598 FUBP3 CNOT3	1.21e-05	231	189	11	int:CNOT9
Interaction	RUNX1 interactions	TCF12 GATA2 RUNX1 SEC31B MSTO1 FAF1 NCOR2 PKD1 KMT2A FIP1L1 SPEN CNOT3 PML	1.24e-05	324	189	13	int:RUNX1
Interaction	MED17 interactions	TENT4B MED14 MED13L RUNX1 SRCAP SCAF4 PPARGC1A KMT2A MED13 PML	2.18e-05	202	189	10	int:MED17
Interaction	FEV interactions	ZNF703 KMT2B EP400 FBRS DACH1 NCOR2 SALL1 WIZ KMT2A FOXK1	2.27e-05	203	189	10	int:FEV
Interaction	PRMT2 interactions	KDM6B KANK2 GJA3 KRBA1 SALL2 FIP1L1 HTT	2.38e-05	91	189	7	int:PRMT2
Interaction	ASF1A interactions	KMT2B EP400 SRCAP PRDM2 NCOR2 SALL2 WIZ KMT2A FIP1L1 SPEN PML	2.43e-05	249	189	11	int:ASF1A
Interaction	CSNK2B interactions	PCGF2 KMT2B EP400 RPS6KA2 ZMYND8 FBRS PER1 KDM6B CDC42BPB CHRNA4 FAF1 ZNF106 SETD2 WIZ KMT2A UNK TOP2A PML	2.56e-05	625	189	18	int:CSNK2B
Interaction	CNOT3 interactions	ATXN2L MAP1A MED14 RUNX1 TOB1 FAM120C UNK FUBP3 CNOT3 HTT	2.69e-05	207	189	10	int:CNOT3
Interaction	CRX interactions	EP400 FBRS TNS2 PROSER1 KANK2 NCOR2 SALL1 WIZ SPEN FOXK1 BAHCC1	2.92e-05	254	189	11	int:CRX
Interaction	BCOR interactions	PCGF2 ERG RPS6KA2 FBRS GATA2 NCOR2 SALL1 SEC16A PAX2 FUBP3 FOXI1 PML	2.96e-05	302	189	12	int:BCOR
Interaction	NXF2 interactions	MAP1A PER1 NUP214 ZNF106 SETD2 ATXN2	3.28e-05	65	189	6	int:NXF2
Interaction	GSK3A interactions	FAM193B MAP1A MAP2 KIF26B RUNX1 RFX7 KANK2 RTN1 KRBA1 MAST4 SEC16A UNK BRSK1 SRRM2 GOLGA3	3.38e-05	464	189	15	int:GSK3A
Interaction	DSN1 interactions	CHAMP1 SALL2 SALL1 WIZ SRRM2 HTT PML	3.60e-05	97	189	7	int:DSN1
Interaction	ESRRB interactions	EP400 ZMYND8 MED14 MED13L RUNX1 PRDM2 SETD2 SALL1 WIZ KIAA1217 MED13	3.88e-05	262	189	11	int:ESRRB
Interaction	CBX3 interactions	PCGF2 KMT2B EP400 ZMYND8 FBRS DACH1 RUNX1 KDM6B CHAMP1 FAF1 SETD2 WIZ KMT2A UNK ZNF830 SRRM2 SPEN TOP2A	3.94e-05	646	189	18	int:CBX3
Interaction	CEBPA interactions	ATXN2L ASXL1 TCF12 KMT2B EP400 RBM10 ZMYND8 GATA2 MED14 DACH1 MED13L RUNX1 E2F8 PRDM2 SCAF4 NCOR2 WIZ ATXN2 CDK13 KMT2A FIP1L1 SRRM2 SPEN FUBP3 TOP2A FOXK1 PML	4.03e-05	1245	189	27	int:CEBPA
Interaction	YTHDF2 interactions	ATXN2L PTPN23 ZCCHC2 FAF1 ATXN2 IFITM3 FAM120C UNK ZNF598 FUBP3 CNOT3 PML	4.06e-05	312	189	12	int:YTHDF2
Interaction	YWHAZ interactions	RALGAPA1 ATXN2L TICRR ASXL1 NUMBL MAP2 KIF26B PPFIA2 WASF3 SYNPO PPFIA3 KANK2 E2F8 FAF1 CCDC88C MAST4 CLK3 STARD9 MARK4 KMT2A UNK ULK1 ZNF598 GOLGA3 FOXK1 HTT OTOG PML	4.17e-05	1319	189	28	int:YWHAZ
Interaction	ATXN1 interactions	ATXN2L FAM193B KMT2B ERG NUMBL RBM10 GATA2 PTPN23 ANKHD1 HEYL NCOR2 SETD2 ATXN2 CDK13 TOX3 UNK PAX2 SRRM2 SPEN FUBP3 CNOT3 TOP2A FOXK1 PML	4.22e-05	1039	189	24	int:ATXN1
Interaction	ERC2 interactions	PPFIA2 PPFIA3 RGS14 HTT PML	4.42e-05	42	189	5	int:ERC2
Interaction	NAA40 interactions	ATXN2L FAM193B EP400 MAP1A NUMBL RBM10 NACA ZMYND8 PTPN23 NUP214 SRCAP ANKHD1 CHAMP1 RTN1 SCAF4 SETD2 WIZ KIAA1217 SEC16A KMT2A ZNF598 TOP2A PML	4.70e-05	978	189	23	int:NAA40
Interaction	CNOT2 interactions	ANKHD1 NCOR2 TOB1 FAM120C SEC16A UNK FUBP3 CNOT3 HTT	4.79e-05	178	189	9	int:CNOT2
Interaction	FMR1 interactions	ATXN2L NUMBL ZMYND8 NCOR2 AATK ATXN2 IFITM3 FAM120C KIAA1217 CASKIN1 UNK BRSK1 ZNF598 FUBP3 CNOT3 TOP2A	4.80e-05	536	189	16	int:FMR1
Interaction	SEC16A interactions	PTPN23 SYNPO ANKHD1 KANK2 NCOR2 ATXN2 IFITM3 FAM120C KIAA1217 SEC16A FIP1L1 ULK1 FUBP3 PML	5.21e-05	426	189	14	int:SEC16A
Interaction	HNF4A interactions	KMT2B EP400 MED14 DACH1 SRCAP PPARGC1A NCOR2 WIZ SPEN KAT14 PML	6.01e-05	275	189	11	int:HNF4A
Interaction	KLF3 interactions	KMT2B EP400 FBRS RFX7 PRDM2 NCOR2 WIZ KMT2A KAT14 FOXK1	6.08e-05	228	189	10	int:KLF3
Interaction	SMC5 interactions	ATXN2L EP400 RBM10 ZMYND8 DACH1 RRP8 NUP214 CHAMP1 SCAF4 NCOR2 SETD2 SALL1 WIZ ATXN2 SEC16A KMT2A FIP1L1 ZNF830 SRRM2 SPEN FUBP3 TOP2A PML	6.59e-05	1000	189	23	int:SMC5
Interaction	PML interactions	MAGEA2 SAP25 TCF12 KMT2B EP400 MAP1A NUMBL GATA2 SYNPO RUNX1 PPARGC1A NCOR2 ZNF106 PIAS3 SEC16A KMT2A FIP1L1 PLAGL1 TOP2A FOXK1 HTT PML	6.68e-05	933	189	22	int:PML
Interaction	PIN1 interactions	TCF12 KMT2B GPR152 TNS2 RBBP8NL CHAMP1 NCOR2 WIZ TOX3 SRRM2 TOP2A FOXI1 PML	7.00e-05	383	189	13	int:PIN1
Interaction	MEX3A interactions	ASXL1 ZMYND8 CDC42BPB FAM120C FARP1 SEC16A UNK AP4M1 FUBP3 CNOT3 TOP2A GOLGA3 FOXK1	7.19e-05	384	189	13	int:MEX3A
Interaction	CPEB1 interactions	MAP2 PPP1R13B ANKHD1 ATXN2 FIP1L1 UNK FUBP3 CNOT3	7.22e-05	146	189	8	int:CPEB1
Interaction	TNRC6B interactions	FBRS PTPN23 KANK2 CEP120 ATXN2 FAM120C SEC16A UNK FUBP3 CNOT3 PML	7.53e-05	282	189	11	int:TNRC6B
Interaction	KDM1A interactions	KMT2B EP400 ZMYND8 FBRS GATA2 NUP214 RBBP8NL ANKHD1 CHAMP1 MSTO1 PRDM2 NCOR2 SALL2 WIZ KIAA1217 SEC16A UNK ZNF598 KAT14 CNOT3 GOLGA3 HTT	7.57e-05	941	189	22	int:KDM1A
Interaction	NR1I3 interactions	MED14 PPARGC1A NCOR2 MED13 PML	8.49e-05	48	189	5	int:NR1I3
Interaction	PRPF40A interactions	ATXN2L KMT2B ERG WASF3 SCAF4 PIAS3 CDK13 MARK4 FIP1L1 ZNF598 SRRM2 SPEN HTT PML	8.49e-05	446	189	14	int:PRPF40A
Interaction	NUP43 interactions	ZNF703 KMT2B EP400 AVPR2 ZMYND8 NUP214 SRCAP CHAMP1 PRDM2 NCOR2 SETD2 SALL2 TOX3 KMT2A SRRM2 SPEN TOP2A	8.73e-05	625	189	17	int:NUP43
Interaction	PPIA interactions	ASXL1 EPS8L2 EP400 MAP1A NACA ZMYND8 PTPN23 SEC31B CHAMP1 KANK2 SCAF4 PTPRN STARD9 SEC16A VGLL4 ZNF598 SRRM2 FUBP3 CNOT3 TOP2A PML	9.48e-05	888	189	21	int:PPIA
Interaction	ACTN1 interactions	NUMBL MAP2 SYNPO2L MED14 SYNPO FAF1 RGS14 ATXN2 IFITM3 PKD1 HTT PML	9.50e-05	341	189	12	int:ACTN1
Interaction	P4HA3 interactions	MAGEA2 KMT2B ZMYND8 FBRS SRCAP FAM120C TOX2	9.54e-05	113	189	7	int:P4HA3
Interaction	RPA4 interactions	ATXN2L TENT4B RBM10 NACA NUP214 ANKHD1 CHAMP1 SETD2 SALL2 CDK13 STARD9 SEC16A FUBP3 TOP2A	9.78e-05	452	189	14	int:RPA4
Interaction	YY1 interactions	ATXN2L ASXL1 PCGF2 KMT2B EP400 ZMYND8 RRP8 SRCAP PPARGC1A WIZ KMT2A FIP1L1 ZNF830 KAT14	1.02e-04	454	189	14	int:YY1
Interaction	ELF4 interactions	ASXL1 KMT2B EP400 RUNX1 SRCAP FOXK1 PML	1.07e-04	115	189	7	int:ELF4
Interaction	MCRIP2 interactions	ATXN2L ATXN2 FAM120C UNK PML	1.14e-04	51	189	5	int:MCRIP2
Interaction	ELF2 interactions	ASXL1 KMT2B EP400 RUNX1 SRCAP KMT2A FOXK1 PML	1.15e-04	156	189	8	int:ELF2
Interaction	ACTG1 interactions	ASXL1 EPS8L2 EP400 MAP1A KIF26B WASF3 WHAMM SRCAP E2F8 FAF1 RGS14 ZNF598 KAT14 HTT PML	1.21e-04	520	189	15	int:ACTG1
Interaction	CTBP1 interactions	EP400 BCAS3 FBRS RUNX1 PRDM2 NCOR2 WIZ SEC16A KMT2A SRRM2 SPEN FOXK1 HTT	1.25e-04	406	189	13	int:CTBP1
Interaction	PHF20 interactions	KMT2B KDM6B KMT2A KAT14 HTT	1.37e-04	53	189	5	int:PHF20
Interaction	ELK3 interactions	ASXL1 KMT2B EP400 DACH1 NCOR2 WIZ FOXK1	1.39e-04	120	189	7	int:ELK3
Interaction	SP7 interactions	ZNF703 KMT2B EP400 RBM10 FBRS PROSER1 SCAF4 NCOR2 WIZ FUBP3 FOXK1	1.46e-04	304	189	11	int:SP7
Interaction	MED8 interactions	MED14 MED13L SCAF4 KMT2A MED13 UBALD1 PML	1.47e-04	121	189	7	int:MED8
Interaction	FOXP1 interactions	ERG GATA2 PER1 NCOR2 SALL1 UNK PAX2 TOP2A HTT FOXI1	1.58e-04	256	189	10	int:FOXP1
Interaction	AR interactions	MAGEA2 ASXL1 ERG EFCAB6 EP400 RBM10 ZMYND8 FBRS MED14 MED13L RUNX1 SRCAP CHAMP1 NCOR2 WIZ PIAS3 KIAA1217 SEC16A KMT2A FUBP3 MED13 FOXK1	1.61e-04	992	189	22	int:AR
Interaction	HELZ interactions	FBRS ZCCHC2 NCOR2 ATXN2 FAM120C CLK3 SEC16A UNK FUBP3 CNOT3	1.63e-04	257	189	10	int:HELZ
Interaction	MCRIP1 interactions	ATXN2L ATXN2 FAM120C UNK FUBP3	1.94e-04	57	189	5	int:MCRIP1
Interaction	NCOR2 interactions	ERG GATA2 RUNX1 NCOR2 CLK3 SEC16A PAX2 SPEN FOXI1 PML	2.03e-04	264	189	10	int:NCOR2
Interaction	ASH2L interactions	KMT2B MED14 RUNX1 KDM6B SRCAP SETBP1 KMT2A KAT14 FOXK1 HTT	2.09e-04	265	189	10	int:ASH2L
Interaction	GATA1 interactions	FBRS MED14 TNS2 RUNX1 KANK2 NCOR2 FUBP3 PML	2.16e-04	171	189	8	int:GATA1
Interaction	EGR2 interactions	EP400 FBRS PROSER1 NCOR2 WIZ SEC16A KMT2A BAHCC1	2.16e-04	171	189	8	int:EGR2
Interaction	MED14 interactions	MED14 MED13L SCAF4 PPARGC1A KMT2A UNK CNOT3 MED13	2.16e-04	171	189	8	int:MED14
Interaction	YWHAB interactions	RALGAPA1 ATXN2L TICRR NUMBL MAP2 KIF26B WASF3 TNS2 RFX7 E2F8 CCDC88C ZNF106 MAST4 CLK3 STARD9 MARK4 KMT2A UNK SRRM2 FOXK1 HTT OTOG	2.20e-04	1014	189	22	int:YWHAB
Interaction	MED7 interactions	EP400 MED14 MED13L CNOT3 MED13 PML	2.30e-04	92	189	6	int:MED7
Interaction	MED15 interactions	MED14 MED13L SRCAP KMT2A CNOT3 MED13 PML	2.39e-04	131	189	7	int:MED15
Interaction	MEX3B interactions	ATXN2L FAM193B PPP1R13B ANKHD1 ATXN2 SEC16A ZNF598 FUBP3 CNOT3	2.56e-04	222	189	9	int:MEX3B
Interaction	BAG2 interactions	ZNF703 ASXL1 PPP1R13B ARHGAP17 PTPN23 ANKHD1 SALL2 WIZ IFITM3 ZNF598 SRRM2 SPEN CNOT3 FOXK1 HTT PML	2.65e-04	622	189	16	int:BAG2
Interaction	MEN1 interactions	ATXN2L TENT4B KMT2B EP400 RBM10 ZMYND8 MED14 RRP8 RUNX1 SRCAP CHAMP1 WIZ FAM120C FARP1 SETBP1 KMT2A FIP1L1 SRRM2 SPEN FUBP3 TOP2A FOXK1	2.69e-04	1029	189	22	int:MEN1
Interaction	KMT2C interactions	ASXL1 KMT2B ERG GATA2 KMT2A PAX2 FOXI1	2.75e-04	134	189	7	int:KMT2C
Interaction	FHL3 interactions	AMH GATA2 TNS2 ANKHD1 KANK2 E2F8 AATK ATXN2 FOXK1 PML	2.89e-04	276	189	10	int:FHL3
Interaction	HDAC1 interactions	KMT2B EFCAB6 EP400 BCAS3 ZMYND8 FBRS DACH1 NUP214 RUNX1 ANKHD1 NCOR2 SALL1 WIZ PIAS3 KMT2A PLAGL1 SPEN KAT14 TOP2A GOLGA3 FOXK1 PML BAHCC1	2.96e-04	1108	189	23	int:HDAC1
Interaction	DTX2 interactions	ZNF703 RBM10 DCBLD1 RUNX1 RFX7 KANK2 NCOR2 SEC16A FIP1L1 FUBP3 FOXI1	2.96e-04	330	189	11	int:DTX2
Interaction	MAU2 interactions	RBM10 MED13L KDM6B SRCAP NMB FUBP3 MED13	3.01e-04	136	189	7	int:MAU2
Interaction	H2BC21 interactions	TICRR PCGF2 KMT2B EP400 ZMYND8 KDM6B SRCAP CHAMP1 PRDM2 SCAF4 PPARGC1A WIZ KMT2A SRRM2 KAT14 TOP2A BAHCC1	3.12e-04	696	189	17	int:H2BC21
Interaction	ZFP36 interactions	PPP1R13B NUP214 KANK2 ATXN2 SEC16A ZNF598 FUBP3 CNOT3	3.17e-04	181	189	8	int:ZFP36
Interaction	SMAD3 interactions	ATXN2L TCF12 KMT2B DACH1 NUP214 RUNX1 KDM6B HEYL SETD2 TOB1 PIAS3 PLAGL1 PML	3.20e-04	447	189	13	int:SMAD3
Interaction	SLX4 interactions	TCF12 ERG EP400 RBM10 NACA NUP214 ANKHD1 CHAMP1 ZNF106 SALL2 SALL1 WIZ PIAS3 KAT14 PML	3.38e-04	572	189	15	int:SLX4
Interaction	ALG13 interactions	ZNF703 FBRS NCOR2 ATXN2 FAM120C SEC16A UNK FUBP3	3.41e-04	183	189	8	int:ALG13
Interaction	CNOT10 interactions	AATK TOB1 FAM120C UNK FUBP3 CNOT3 HTT	3.75e-04	141	189	7	int:CNOT10
Interaction	PHF21A interactions	KMT2B ZMYND8 FBRS NUP214 ANKHD1 SALL2 SALL1 SEC16A KAT14 GOLGA3 PML	4.11e-04	343	189	11	int:PHF21A
Interaction	SMARCA4 interactions	TENT4B ERG EP400 ZMYND8 GATA2 RUNX1 KDM6B SRCAP NCOR2 MARK4 SRRM2 TOP2A PML	4.37e-04	462	189	13	int:SMARCA4
Interaction	NCOA6 interactions	KMT2B ERG GATA2 PPARGC1A NCOR2 KMT2A HTT	4.44e-04	145	189	7	int:NCOA6
Interaction	LYN interactions	SPHK2 NUMBL KIF26B TFDP3 PPP1R13B KANK2 CDC42BPB CCDC88C IFITM3 FARP1 KIAA1217 TOX3 KMT2A ULK1 SRRM2 FUBP3 HTT	4.59e-04	720	189	17	int:LYN
Interaction	HCFC1 interactions	ASXL1 KMT2B EP400 RUNX1 PPARGC1A KMT2A NYAP1 KAT14 FOXK1 PML	4.63e-04	293	189	10	int:HCFC1
Interaction	EYA4 interactions	ATXN2L ZNF703 TPRN FBRS GATA2 PROSER1 RFX7 NCOR2 AATK	4.96e-04	243	189	9	int:EYA4
Interaction	MED26 interactions	MED14 MED13L RUNX1 SCAF4 MED13 PML	5.18e-04	107	189	6	int:MED26
Interaction	GATA4 interactions	TCF12 ERG EP400 PROSER1 NCOR2 SALL2 SALL1 CEP120 WIZ KMT2A SRRM2 TOP2A	5.24e-04	411	189	12	int:GATA4
Cytoband	11p15.5	EPS8L2 MUC5B IFITM3 MUC2 MUC6	1.35e-04	118	189	5	11p15.5
Cytoband	19q13.4	LILRA6 DNAAF3 BRSK1 CNOT3	3.29e-04	79	189	4	19q13.4
Cytoband	16q12.1	TENT4B SALL1 TOX3	3.74e-04	34	189	3	16q12.1
Cytoband	16p13.3	NTN3 CASKIN1 PKD1 ZNF598 SRRM2 UBALD1	5.51e-04	244	189	6	16p13.3
Cytoband	Ensembl 112 genes in cytogenetic band chr11p15	EPS8L2 RRP8 MUC5B E2F8 IFITM3 DBX1 MUC2 MUC6 OTOG	5.94e-04	564	189	9	chr11p15
GeneFamily	CD molecules\|Mucins	MUC5B MUC12 MUC2 MUC4 MUC6	3.06e-07	21	128	5	648
GeneFamily	Ataxins\|Trinucleotide repeat containing	EP400 NUMBL NCOR2 ATXN2 TOX3	7.80e-07	25	128	5	775
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B PRDM2 SETD2 KMT2A	9.43e-05	34	128	4	487
GeneFamily	Cyclins\|Mediator complex	MED14 MED13L MED13	1.62e-03	33	128	3	1061
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF438 ZNF619 ZNF467 CHAMP1 HIVEP3 ZNF106 SALL2 SALL1 WIZ ZNF358 ZNF197 PLAGL1 ZNF598	1.75e-03	718	128	13	28
Coexpression	ZHONG_PFC_C3_ASTROCYTE	CACNA1B FAM193B PPFIA2 GAS7 SEC31B CDC42BPB PRDM2 KIAA0319 COL18A1 NCOR2 NRXN2 PKD1 KMT2A SYT5 GOLGA3	1.67e-07	389	189	15	M39102
Coexpression	GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	ATXN2L SPHK2 SAP25 RBM10 ARHGAP17 NUP214 SRCAP SEC31B MSTO1 HEYL ZNF358 ZNF598 SRRM2 CNOT3	1.84e-07	338	189	14	M17094
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	RALGAPA1 TICRR ASXL1 KMT2B RFX7 ZNF106 SETD2 ULK1 TOX2 MED13	7.92e-07	180	189	10	M8239
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	RALGAPA1 TCF12 BCAS3 DACH1 MED13L FAF1 PPARGC1A SETBP1 TOX3	4.44e-06	171	189	9	M39234
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	ASXL1 EFCAB6 RPS6KA2 RUNX1 MAST4 KMT2A RIPOR1 VGLL4 MUC4 MYRF PML	6.28e-06	279	189	11	M16867
Coexpression	GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP	FAM193B COL27A1 RCSD1 ANKHD1 KRBA1 ADAMTS7 CLK3 MARK4 MED13	1.57e-05	200	189	9	M3312
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ZNF703 TCF12 MAP1A COL20A1 BCAS3 COL27A1 ZMYND8 FGFRL1 GAS7 SYNPO SRCAP ANKHD1 DSCAML1 E2F8 SCAF4 TTBK1 AATK PER3 ULK1 BRSK1 MYRF HTT	1.62e-05	1102	189	22	M2369
Coexpression	PEREZ_TP53_TARGETS	EPS8L2 MXRA5 KIF26B COL27A1 GATA2 SCAF4 DNAAF3 HEPACAM GJA3 COL18A1 KRBA1 HEG1 ARHGEF40 HOXC5 CEP120 ADAMTS7 CLK3 KIAA1217 MARK4 ULK1 MUC2 TOX2 MYRF	1.98e-05	1201	189	23	M4391
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	ZNF703 TCF12 MAP1A COL20A1 BCAS3 COL27A1 ZMYND8 FGFRL1 GAS7 SYNPO SRCAP ANKHD1 DSCAML1 E2F8 SCAF4 TTBK1 AATK PER3 ULK1 BRSK1 MYRF HTT	2.18e-05	1124	189	22	MM1070
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL	MAP2 DACH1 NPDC1 RTN1 NACAD HIVEP3 PTPRN SETBP1 TOX3 SYT5	2.67e-05	268	189	10	M45696
Coexpression	GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP	CD164L2 AMH ERG GATA2 SEC31B HIVEP3 IFITM3 TOX3	2.76e-05	165	189	8	M6880
Coexpression	AIZARANI_LIVER_C10_MVECS_1	ERG RPS6KA2 TNS2 NPDC1 SYNPO HEG1 MAST4 IFITM3 CD300LG RIPOR1	2.76e-05	269	189	10	M39114
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_3_DN	RALGAPA1 MXRA5 COL27A1 SEC31B ARHGEF40 SALL2 MAST4 CLK3 PML	4.10e-05	226	189	9	M11238
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	MAP2 PPFIA2 ZMYND8 NPDC1 MED13L RFX7 SEC31B RTN1 DSCAML1 CHRNA4 PRDM2 HIVEP3 PPARGC1A AATK MAST4 NRXN2 CASKIN1 TOX3 MUC2 TOX2 GOLGA3	5.26e-05	1106	189	21	M39071
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	RALGAPA1 DACH1 MED13L RUNX1 KDM6B SCAF4 RGS14 MARK4 PLAGL1	5.93e-05	237	189	9	M7068
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP	RPS6KA2 TNS2 ZNF467 SEC31B GPR162 RGS14 LIPE MAST4	9.29e-05	196	189	8	M4423
Coexpression	GSE29618_PDC_VS_MDC_UP	MAP1A RPS6KA2 SERPINF1 DACH1 ARHGAP4 PIAS3 SETBP1 RIPOR1	9.97e-05	198	189	8	M4951
Coexpression	GSE360_DC_VS_MAC_DN	RPS6KA2 NACA GAS7 ARHGAP4 HOXC5 AATK SYT5 MUC6	9.97e-05	198	189	8	M5173
Coexpression	GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP	DACH1 PPP1R13B RCSD1 ZNF619 ZNF467 KANK2 HIVEP3 IFITM3	1.03e-04	199	189	8	M7491
Coexpression	CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP	ZNF703 NACA DACH1 NPDC1 ZNF467 FRMD4A TOB1 ATXN2 SEC16A ULK1 SRRM2	1.19e-04	385	189	11	M2840
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TCF12 ERG NACA PER1 GAS7 NUP214 RUNX1 KMT2A FIP1L1 PML	1.27e-04	323	189	10	M9150
Coexpression	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	ZNF703 TCF12 RNF19B GATA2 FARP1 KIAA1217 ZC3H12C TOX2 BAHCC1	1.39e-04	265	189	9	M2255
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	RALGAPA1 TCF12 BCAS3 DACH1 FAF1 PPARGC1A KIAA1217 TOX3	1.40e-04	208	189	8	M39233
Coexpression	GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP	PCGF2 WHAMM NPDC1 ZCCHC2 HEG1 PLAGL1 PML	1.49e-04	157	189	7	M6867
Coexpression	DELACROIX_RAR_BOUND_ES	ZNF438 PCGF2 KDM6B HIVEP3 LIPE SALL2 WIZ ATXN2 FAM120C BRSK1 SPEN FUBP3	1.51e-04	465	189	12	M2466
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML5	MAP2 PPFIA2 GATA2 SEC31B RTN1 HIVEP3 AATK NRXN2 CASKIN1 TOX3 ZC3H12C TOX2	1.51e-04	465	189	12	M39066
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TCF12 WASF3 ZMYND8 MED13L RUNX1 SETD2 HEG1 ATXN2 CDK13 SPEN TOP2A MED13	1.55e-04	466	189	12	M13522
Coexpression	NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	EP400 ULK1 GOLGA3	1.58e-04	15	189	3	M8432
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	EFCAB6 MAP1A MAP2 PRR30 RTN1 HIVEP3 CCDC88C PPARGC1A SALL1 NRXN2 ADAMTS7 SETBP1 TOX3 PAX2 ZC3H12C TOX2	8.73e-06	496	187	16	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05	ZNF703 MAP2 DACH1 RTN1 NACAD HOXC5 TOB1 NRXN2 PTPRN CASKIN1 SETBP1 TOX3 PKD1 ZC3H12C ROBO3 BRSK1 NYAP1 TOX2 UBALD1	2.43e-05	727	187	19	PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	TICRR PCGF2 TCF12 MAP1A NUMBL MAP2 PPFIA2 MED14 ARHGAP17 NPDC1 RTN1 E2F8 FAF1 CCDC88C PPARGC1A HEG1 SALL1 ADAMTS7 ZNF358 SETBP1 TOX3 FIP1L1 SYT5 ZC3H12C TOX2 MYRF TOP2A	7.03e-05	1370	187	27	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2	MAP1A PPFIA2 RTN1 CCDC88C PPARGC1A AATK NRXN2 TOX3 PLAGL1 TOX2	7.30e-05	248	187	10	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	RPS6KA2 DCBLD1 COL18A1 STARD9 MARK4	8.49e-05	51	187	5	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#3	SPHK2 PTPN23 CHAMP1 CCDC88C NCOR2 SALL1 TOX3 ZNF830 ROBO3 FUBP3 CNOT3	1.00e-04	310	187	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4	MAP1A NUMBL MAP2 PPFIA2 DACH1 NPDC1 RTN1 CCDC88C PPARGC1A AATK NRXN2 ADAMTS7 SETBP1 TOX3 PLAGL1 ZC3H12C TOX2	1.19e-04	683	187	17	Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	EPS8L2 MAP2 WASF3 UPK3B SYNPO KANK2 PPARGC1A COL18A1 HEG1 AATK FARP1 MYRF	2.32e-11	183	189	12	6821dca076318115d360ff426eb1218cfe104063
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 PPFIA2 COL27A1 DACH1 TNS2 KANK2 SALL1 ADAMTS7 IFITM3 FARP1	1.31e-08	197	189	10	236a40eb6c08e1d179cf0fb5450b032975c5f6b6
ToppCell	AT1-AT2_cells-Donor_06\|World / lung cells shred on cell class, cell subclass, sample id	MAP2 WASF3 UPK3B PPP1R13B SYNPO PPARGC1A AATK ZC3H12C MYRF	6.36e-08	175	189	9	bdd85ba280648a0283c1984662a34c7b840f64dd
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD164L2 MAP2 AVPR2 KIF26B GATA2 COL18A1 TOX3 MUC4 FOXI1	1.17e-07	188	189	9	315ce1736e3a84a63a8d5dfa70d411b501cb2532
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	EPS8L2 MAP2 WASF3 UPK3B SYNPO COL18A1 HEG1 AATK MYRF	1.40e-07	192	189	9	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	5'-Adult-LymphNode-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG AVPR2 RPS6KA2 GATA2 TNS2 ZNF467 IFITM3 CD300LG ROBO3	1.82e-07	198	189	9	d7e15e61b6018e4c36461c9471ee29601929925c
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	KIF26B RPS6KA2 HEG1 SLC9A2 ARHGEF40 FARP1 KIAA1217 TOX3 TOX2	1.99e-07	200	189	9	347a510755374c6a66acee326565dfc447993f18
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	ERG GATA2 DACH1 RCSD1 HEG1 KIAA1217 PLAGL1 ZC3H12C TOX2	1.99e-07	200	189	9	432384faeade8e609154fab3d96c955a8ec868dd
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 ERG COL27A1 GPR152 HEYL ADAMTS7 PTPRN ENPEP	8.17e-07	174	189	8	268be5e7d2a18b866770b7cdb966c3958c7e6534
ToppCell	facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPS8L2 ERG COL27A1 GPR152 HEYL ADAMTS7 PTPRN ENPEP	8.17e-07	174	189	8	4cdf2eedc28d88d18241ee390092426fdf849e79
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	PPFIA2 COL27A1 FRMD4A COL18A1 HEYL SETBP1 TOX2 ENPEP	1.01e-06	179	189	8	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TENT4B KIF26B DCBLD1 TNS2 RRP8 PKD1 VGLL4 MED13	1.19e-06	183	189	8	3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f
ToppCell	Endothelial-A-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	ERG AVPR2 DACH1 NPDC1 COL18A1 HEG1 CD300LG TOX2	1.29e-06	185	189	8	dee0b7ba2f338f0979d2306aedf52ac35a36b60c
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L ZNF703 PER1 FGFRL1 KDM6B NCOR2 HEG1 CDK13	1.35e-06	186	189	8	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	E17.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SERPINF1 GATA2 NPDC1 COL18A1 HEG1 MAST4 TOX3 TOX2	1.46e-06	188	189	8	59f276e23c8380bae57d7ecca3a8b83df4bc150b
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 RCSD1 HEG1 KIAA1217 ZC3H12C TOX2	1.46e-06	188	189	8	73f6ec915934154f435a376cb274b058ff7c5f35
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN2L ZNF703 PER1 FGFRL1 SYNPO KDM6B NCOR2 CDK13	1.52e-06	189	189	8	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG MAP2 DACH1 NPDC1 HEG1 KIAA1217 ZC3H12C TOX2	1.58e-06	190	189	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	ERG MAP2 COL27A1 DACH1 DCBLD1 HEYL IFITM3 ENPEP	1.58e-06	190	189	8	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG RPS6KA2 GATA2 NPDC1 SYNPO HEG1 MAST4 IFITM3	1.58e-06	190	189	8	ec6b8e2852e1cce0217ff61243defe98b2351640
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)\|343B / Donor, Lineage, Cell class and subclass (all cells)	ERG GATA2 NPDC1 SYNPO PPFIA3 HEG1 PNPLA1 TOX2	1.64e-06	191	189	8	27a532a35d9e8822014f581fd56c4ca62e39f8fe
ToppCell	343B-Endothelial_cells-Endothelial-B_(Artery)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ERG GATA2 NPDC1 SYNPO PPFIA3 HEG1 PNPLA1 TOX2	1.64e-06	191	189	8	1dfcff08e01e6a695953334342bcfde04ba005ad
ToppCell	LAM-Epithelial-AT1\|Epithelial / Condition, Lineage and Cell class	EPS8L2 MAP2 WASF3 UPK3B SYNPO KANK2 HEG1 MYRF	1.64e-06	191	189	8	3457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TCF12 BCAS3 DACH1 MED13L FAF1 MAST4 FARP1 SETBP1	1.71e-06	192	189	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 RCSD1 HEG1 KIAA1217 ZC3H12C TOX2	1.71e-06	192	189	8	c618ede75dce3988c87a5b8f98d8e94e1dd66efd
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD164L2 AVPR2 KIF26B GATA2 DACH1 COL18A1 TOX3 FOXI1	1.78e-06	193	189	8	536b277d90070c4571c592a3c6323b4bf4819f67
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CD164L2 AVPR2 KIF26B GATA2 DACH1 COL18A1 TOX3 FOXI1	1.78e-06	193	189	8	0499611c21d283321ef6dd24add154dea48da1b7
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 HEG1 KIAA1217 TOX3 ZC3H12C TOX2	1.85e-06	194	189	8	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	MAP1A MAP2 GATA2 NACAD TTBK1 PTPRN SYT5 NYAP1	1.85e-06	194	189	8	b6488bc3a8905e926ad298332963e1bbaf010046
ToppCell	TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma\|TCGA-Adrenal / Sample_Type by Project: Shred V9	MAP1A MAP2 GATA2 NACAD TTBK1 PTPRN SYT5 NYAP1	1.85e-06	194	189	8	1e1f4139ad584f493d75a9b7f1568eca4653c5a2
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 HEG1 KIAA1217 TOX3 ZC3H12C TOX2	1.85e-06	194	189	8	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG GATA2 NPDC1 SYNPO HEG1 MAST4 IFITM3 CD300LG	1.92e-06	195	189	8	b0979c1b5e4576468b8fe4e9027650859e598b34
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPS8L2 MAP2 WASF3 UPK3B SYNPO AATK FARP1 MYRF	1.92e-06	195	189	8	2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPS8L2 MAP2 WASF3 UPK3B SYNPO AATK FARP1 MYRF	1.92e-06	195	189	8	68f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPS8L2 MAP2 WASF3 UPK3B SYNPO AATK FARP1 MYRF	1.99e-06	196	189	8	6731fef8c148b6681d6ed38afdf23c8213e0bbbe
ToppCell	medial-Endothelial-Capillary_Intermediate_2-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCGF2 ERG NPDC1 SYNPO HEG1 IFITM3 CD300LG TOX2	1.99e-06	196	189	8	5cc14a5797884ff3a007683048e690a0d7172fc4
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPS8L2 MAP2 WASF3 UPK3B SYNPO AATK FARP1 MYRF	1.99e-06	196	189	8	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	medial-Endothelial-Capillary_Intermediate_2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCGF2 ERG NPDC1 SYNPO HEG1 IFITM3 CD300LG TOX2	1.99e-06	196	189	8	07e6214e771c65574f0ada65e75f4bda265aa47f
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT1\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EPS8L2 MAP2 WASF3 UPK3B SYNPO AATK FARP1 MYRF	1.99e-06	196	189	8	6856317cd0cdcb88fe54b4ae905d91e13495b1c4
ToppCell	medial-2-Endothelial-Capillary_Intermediate_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PCGF2 ERG NPDC1 SYNPO HEG1 IFITM3 CD300LG TOX2	1.99e-06	196	189	8	d074c24fecd0e3ffca4699fb1a9d443e6d9a858d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MXRA5 TNS2 KANK2 COL18A1 HEYL MAST4 STARD9 ENPEP	2.07e-06	197	189	8	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG RPS6KA2 GATA2 TNS2 NPDC1 HEG1 MAST4 IFITM3	2.07e-06	197	189	8	e8e879b7634a29569061d3515d180784094a31e7
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 COL27A1 DACH1 DCBLD1 TNS2 ADAMTS7 IFITM3 FARP1	2.15e-06	198	189	8	09be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B MAP2 PPFIA2 RTN1 PPARGC1A FRMD4A SETBP1 PKD1	2.15e-06	198	189	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	5'-Adult-LargeIntestine-Endothelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG RPS6KA2 GATA2 TNS2 NPDC1 SYNPO HEG1 IFITM3	2.23e-06	199	189	8	ffebd99d55d31cf51b4878b2690ed0b9b3799223
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MXRA5 DACH1 DCBLD1 TNS2 RCSD1 COL18A1 IFITM3 FARP1	2.23e-06	199	189	8	a697b3f0760e66bad8ea8d83cf6fea5934692c56
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ERG RPS6KA2 GATA2 DACH1 ARHGAP4 HEG1 PNPLA1 TOX2	2.23e-06	199	189	8	9735a1dc10910f02f1106b20ae5ab4c09c21305e
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 GATA2 DACH1 PPARGC1A COL18A1 SLC9A2 TOX3 PAX2	2.23e-06	199	189	8	3cd6383c50ce342fe5c175e2e50784d634a90e80
ToppCell	Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ERG MAP2 GATA2 SYNPO ARHGAP4 HEG1 MAST4 TOX2	2.32e-06	200	189	8	5ec31c1be6bcc4124e1489d136570f3de33cc2e9
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ERG GATA2 TNS2 NPDC1 SYNPO HEG1 MAST4 IFITM3	2.32e-06	200	189	8	cd3c638961144a2fc91c437a173cc37c7452fa74
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ERG RPS6KA2 GATA2 DACH1 RCSD1 HEG1 KIAA1217 TOX2	2.32e-06	200	189	8	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	CLCA4 ERG RPS6KA2 GATA2 DACH1 HEG1 MAST4 TOX2	2.32e-06	200	189	8	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	RALGAPA1 ERG RPS6KA2 GATA2 DACH1 ARHGAP4 HEG1 MAST4	2.32e-06	200	189	8	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	ERG RPS6KA2 GATA2 DACH1 HEG1 MAST4 KIAA1217 PML	2.32e-06	200	189	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	Parenchymal-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NUMBL MAP2 SERPINF1 COL18A1 HEYL STARD9 CASKIN1 NYAP1	2.32e-06	200	189	8	4c3c11dd5e71ebc3d62264eeaeb71a850b149779
ToppCell	Parenchyma_COVID-19-Endothelial-TX-Capillary\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	ERG GATA2 DACH1 NPDC1 HEG1 IFITM3 CD300LG TOX2	2.32e-06	200	189	8	6c0498a5868891e8e22c03469d00669b20249b1a
ToppCell	Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ERG GATA2 DACH1 NPDC1 SYNPO HEG1 MAST4 TOX2	2.32e-06	200	189	8	ac6b8bc9998d303f788511b8f111e682ea9f3df8
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	ERG RPS6KA2 GATA2 DACH1 HEG1 MAST4 KIAA1217 PML	2.32e-06	200	189	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ERG GATA2 DACH1 NPDC1 HEG1 IFITM3 CD300LG TOX2	2.32e-06	200	189	8	7020045b933cb104fb99b79524cb0d4734b8636d
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ERG RPS6KA2 GATA2 DACH1 MAST4 KIAA1217 TOX3 PML	2.32e-06	200	189	8	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ERG GATA2 DACH1 NPDC1 HEG1 IFITM3 CD300LG TOX2	2.32e-06	200	189	8	e9913511a129bb3cee85e7ebf565b951dab91542
ToppCell	3'-Adult-LymphNode-Endothelial-blood_vessel_EC\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AVPR2 GATA2 NPDC1 SYNPO HEG1 IFITM3 CD300LG RIPOR1	2.32e-06	200	189	8	663e2b4672f193844bb9bf4873749114977c19b3
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ERG AVPR2 GATA2 DACH1 PPFIA3 SETBP1 TOX2	4.95e-06	157	189	7	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	MXRA5 KIF26B PPFIA2 DCBLD1 RUNX1 PTPRN KIAA1217	6.59e-06	164	189	7	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG RPS6KA2 NPDC1 SYNPO E2F8 HEG1 TOX2	7.13e-06	166	189	7	ec719368295133da2f7ff587c5329ed6db1dd56d
ToppCell	356C-Myeloid-Monocyte-CD16+_Monocyte\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	BCAS3 RPS6KA2 DCBLD1 MED13L AATK PIAS3 PKD1	7.42e-06	167	189	7	7e61c5d2cdcfa6a2e3484b3994aec6b64ad75f07
ToppCell	E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TICRR ERG NPDC1 SYNPO CDC42BPB SALL2 ZNF358	8.99e-06	172	189	7	8a6a2b4c6654bc976e60a02d0e7303a9071ed55f
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SERPINF1 GATA2 NPDC1 SYNPO HEG1 MAST4 TOX2	9.34e-06	173	189	7	b0ff9808e38cb64a734ced498cd0546728746cd5
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PCGF2 ERG MAP2 RPS6KA2 SYNPO HEG1 TOX2	9.70e-06	174	189	7	3d4c05ea5719ca65e85d1f15198453034791087c
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1B CD164L2 CLCA4 PPFIA2 WASF3 GPR162 PTPRN	1.01e-05	175	189	7	8362a46f5804333baa84cd56d450bc147f372a7e
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CACNA1B CD164L2 CLCA4 PPFIA2 WASF3 GPR162 PTPRN	1.01e-05	175	189	7	8b4c62e608f0ec84e563bbf0ebffe3ed44085298
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B MAP2 NTN3 DSCAML1 E2F8 CASKIN1 TOX3	1.08e-05	177	189	7	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AVPR2 TNS2 NPDC1 LIPE IFITM3 KIAA1217 CD300LG	1.12e-05	178	189	7	360d7a987f91d6d721487a921824057ec31a7332
ToppCell	Adult-Epithelial-club_cell-D122\|Adult / Lineage, Cell type, age group and donor	EPS8L2 PPARGC1A MAST4 FARP1 KIAA1217 TOX3 MUC4	1.12e-05	178	189	7	35a2e3ba98b6f857dbb79cf8ddb4846ddcda6c17
ToppCell	T_cells-TFH-like_cells\|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis	MAP2 TTBK1 KIAA1217 ZC3H12C NMB TOX2 TOP2A	1.12e-05	178	189	7	e2ae43e5ec31de6197f2cbd6089f944adbf0a163
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Alv_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 RCSD1 KIAA1217 ZC3H12C TOX2	1.21e-05	180	189	7	30cf3c7ee29694eaccb89bf8053a82037d5c9f1d
ToppCell	droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP2 BCAS3 HEYL SLC9A2 AATK SYT5 ENPEP	1.21e-05	180	189	7	78fdcfb3fdbf36469cae78407cda5bd0996930d8
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	MAP2 PPFIA2 COL27A1 DACH1 DSCAML1 HEYL ENPEP	1.25e-05	181	189	7	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP2 PPFIA2 COL27A1 DACH1 DSCAML1 HEYL ENPEP	1.30e-05	182	189	7	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	ERG GATA2 DACH1 RTN1 STARD9 KIAA1217 TOX2	1.30e-05	182	189	7	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	LA-07._Pericyte\|World / Chamber and Cluster_Paper	MAP2 COL27A1 DACH1 DCBLD1 DSCAML1 HEYL ENPEP	1.35e-05	183	189	7	e3835db4795362b0442d5893baf2a78efcc20428
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 KIF26B PPFIA2 MUC5B DSCAML1 PPARGC1A OTOG	1.39e-05	184	189	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EPS8L2 MAP2 UPK3B SYNPO HEG1 AATK MYRF	1.39e-05	184	189	7	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|343B / Donor, Lineage, Cell class and subclass (all cells)	EPS8L2 MAP2 UPK3B SYNPO NCOR2 AATK MYRF	1.39e-05	184	189	7	cb15d6bae52c5ec251c2235859dc7e65f630ae23
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EPS8L2 MAP2 UPK3B SYNPO HEG1 AATK MYRF	1.39e-05	184	189	7	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 KIF26B PPFIA2 MUC5B DSCAML1 PPARGC1A OTOG	1.39e-05	184	189	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	EPS8L2 MAP2 UPK3B SYNPO NCOR2 AATK MYRF	1.39e-05	184	189	7	bde4eaabd3e9bdaed23867d23a919b9d84b52d4b
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EFCAB6 KIF26B PPFIA2 MUC5B DSCAML1 PPARGC1A OTOG	1.39e-05	184	189	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	COL27A1 MED13L RUNX1 DSCAML1 COL18A1 ATXN2 TOX3	1.44e-05	185	189	7	1d874608aa2062024323512f68889219471b2f00
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	MXRA5 ERG MAP2 PPFIA2 SYNPO RUNX1 DSCAML1	1.49e-05	186	189	7	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG DACH1 DCBLD1 SALL2 NRXN2 CDK13 CD300LG	1.49e-05	186	189	7	90d53c2597a9f3a2b39afba75adfc54f1ca0a4db
ToppCell	droplet-Liver-Hepatocytes-24m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERG DACH1 DCBLD1 SALL2 NRXN2 CDK13 CD300LG	1.49e-05	186	189	7	2cae34336f184f971f7c8684cc27c23a4e7369ed
ToppCell	Adult-Endothelial-endothelial_cell_of_artery\|Adult / Lineage, Cell type, age group and donor	ERG GATA2 DACH1 NPDC1 HEG1 SETBP1 TOX2	1.49e-05	186	189	7	2d1c4ea2e401db89971582ee54618a8b0c81b8ac
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	MAP2 COL27A1 DACH1 DCBLD1 DSCAML1 HEYL ENPEP	1.49e-05	186	189	7	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	Endothelial-A-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	ERG GATA2 DACH1 NPDC1 HEG1 CD300LG TOX2	1.55e-05	187	189	7	fd93f3f4b82dae3bf4eef245bfedc2a9e3251b61
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ERG DACH1 NPDC1 RCSD1 HEG1 ZC3H12C TOX2	1.55e-05	187	189	7	f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1
ToppCell	COVID-19-Heart-EC_2\|Heart / Disease (COVID-19 only), tissue and cell type	ERG GATA2 DACH1 CCDC88C ARHGAP4 MAST4 TOX2	1.55e-05	187	189	7	40ffc06a3e3251d9b12da390210d3e045af7537a
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)\|Adult / Lineage, Cell type, age group and donor	ERG GATA2 DACH1 RTN1 KIAA1217 CD300LG TOX2	1.60e-05	188	189	7	e5cad03f4a64147fe8174e7f614cf45233ffb9b7
ToppCell	Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122\|Adult / Lineage, Cell type, age group and donor	ERG GATA2 DACH1 NPDC1 KIAA1217 CD300LG TOX2	1.60e-05	188	189	7	02a62888e9db29d20133eeca1686d302545a39c9
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CACNA1B RTN1 CHRNA4 NRXN2 PTPRN SYT5 PAX2	1.60e-05	188	189	7	bd091503f580dedab40e0996273101285d24b586
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ATXN2L PCGF2 KMT2B EP400 GAS7 TNS2 NPDC1 SYNPO KDM6B SRCAP SCAF4 MAST4 WIZ NMB	1.22e-09	199	188	14	578_UP
Drug	PHA-00665752 [477575-56-7]; Up 200; 10uM; MCF7; HT_HG-U133A	AMH PCGF2 DACH1 PER1 TNS2 MUC5B PPFIA3 SCAF4 ARHGAP4 MARK4 PML BAHCC1	9.48e-08	197	188	12	6578_UP
Drug	Flutamide [13311-84-7]; Up 200; 14.4uM; HL60; HT_HG-U133A	ERG DACH1 TFDP3 TNS2 RUNX1 SEC31B HIVEP3 ARHGAP4 SETBP1 MARK4 MYRF PML	1.00e-07	198	188	12	2358_UP
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Down 200; 10.4uM; PC3; HT_HG-U133A	PCGF2 KMT2B RPS6KA2 GATA2 TNS2 PPFIA3 SCAF4 CCDC88C ZNF358 SETBP1 NMB PML	1.06e-07	199	188	12	7295_DN
Drug	Piperine [94-62-2]; Down 200; 14uM; PC3; HT_HG-U133A	PCGF2 MAP1A RPS6KA2 ZMYND8 FBRS NUP214 RUNX1 SRCAP WIZ CNOT3 PML	5.77e-07	191	188	11	4247_DN
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ATXN2L PER1 TNS2 KDM6B SRCAP PRDM2 MAST4 ZNF358 MARK4 FOXI1 PML	6.73e-07	194	188	11	3861_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A	PCGF2 MAP1A RUNX1 KDM6B RGS14 SLC9A2 WIZ CDK13 ZNF358 CNOT3 PML	6.73e-07	194	188	11	4242_DN
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	ATXN2L RNF19B FBRS RUNX1 CDC42BPB HIVEP3 SLC9A2 HOXC5 WIZ ENPEP CNOT3	7.08e-07	195	188	11	4235_DN
Drug	Antimycin A [1397-94-0]; Down 200; 7.2uM; PC3; HT_HG-U133A	SPHK2 BCAS3 RPS6KA2 MED14 PROSER1 PPFIA3 MAST4 FAM120C MARK4 ROBO3 PML	7.08e-07	195	188	11	5053_DN
Drug	Etodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A	AMH MAP2 RPS6KA2 GAS7 RUNX1 RTN1 HEYL NCOR2 ADAMTS7 CDK13 KMT2A	7.45e-07	196	188	11	2254_UP
Drug	Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; PC3; HT_HG-U133A	AMH ERG NTN3 ZMYND8 TFDP3 GAS7 NUP214 RUNX1 RGS14 HOXC5 MYRF	7.45e-07	196	188	11	3682_UP
Drug	2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A	ASXL1 RBM10 RNF19B FBRS DACH1 TNS2 SCAF4 NCOR2 HEG1 MAST4 PML	7.83e-07	197	188	11	5211_DN
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	SPHK2 PER1 GAS7 RUNX1 RFX7 SCAF4 HIVEP3 FAM120C KMT2A MYRF PML	7.83e-07	197	188	11	3748_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; MCF7; HT_HG-U133A	ATXN2L MAP2 PER1 TFDP3 RUNX1 HIVEP3 HOXC5 MAST4 CDK13 FIP1L1 FOXI1	8.24e-07	198	188	11	3883_DN
Drug	Vitamin K2 [11032-49-8]; Down 200; 9uM; MCF7; HT_HG-U133A	ATXN2L MAP2 FBRS GAS7 TNS2 RUNX1 HIVEP3 WIZ FAM120C CDK13 BAHCC1	8.24e-07	198	188	11	3880_DN
Drug	Levamisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A	RALGAPA1 RNF19B PER1 GAS7 PRDM2 HIVEP3 HEG1 WIZ RIPOR1 PML BAHCC1	8.66e-07	199	188	11	2257_DN
Drug	Etofenamate [30544-47-9]; Up 200; 10.8uM; MCF7; HT_HG-U133A	ATXN2L SYNPO2L GAS7 RUNX1 AATK WIZ SETBP1 SRRM2 CNOT3 PML	4.68e-06	192	188	10	4108_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Down 200; 7.2uM; PC3; HT_HG-U133A	FBRS PER1 RGS14 NCOR2 SLC9A2 MYRF ENPEP CNOT3 PML BAHCC1	4.90e-06	193	188	10	4067_DN
Drug	PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A	ATXN2L RPS6KA2 GATA2 RUNX1 NACAD PRDM2 NCOR2 HEG1 SALL1 PML	4.90e-06	193	188	10	5922_UP
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A	SERPINF1 MED14 DACH1 KANK2 PRDM2 SALL2 PER3 MARK4 RIPOR1 FOXI1	5.13e-06	194	188	10	4411_DN
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	RNF19B ZMYND8 KDM6B SLC9A2 WIZ CDK13 MYRF ENPEP CNOT3 PML	5.13e-06	194	188	10	4246_DN
Drug	Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	AMH NTN3 PER1 SRCAP CDC42BPB RGS14 MARK4 SYT5 SRRM2 SPEN	5.13e-06	194	188	10	6835_UP
Drug	Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	ATXN2L SPHK2 PCGF2 RUNX1 SRCAP HEG1 WIZ MYRF CNOT3 PML	5.13e-06	194	188	10	4335_DN
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A	RALGAPA1 AMH RPS6KA2 SERPINF1 MED14 PER1 SYNPO SRCAP PRDM2 MARK4	5.13e-06	194	188	10	7347_UP
Drug	(R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; MCF7; HT_HG-U133A	KIF26B RPS6KA2 TNS2 NUP214 ARHGAP4 HOXC5 LIPE AATK FAM120C PML	5.37e-06	195	188	10	3553_UP
Drug	Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A	PCGF2 PROSER1 RUNX1 RGS14 MAST4 FAM120C ZNF358 MARK4 ULK1 PML	5.37e-06	195	188	10	4533_DN
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SPHK2 MUC5B SRCAP HIVEP3 FRMD4A RGS14 HOXC5 CDK13 KMT2A PAX2	5.37e-06	195	188	10	3941_DN
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SERPINF1 GAS7 SRCAP ARHGAP4 FRMD4A MARK4 RIPOR1 PAX2 FOXI1 PML	5.37e-06	195	188	10	4180_DN
Drug	Benzathine benzylpenicillin [5928-84-7]; Up 200; 4.2uM; MCF7; HT_HG-U133A	ATXN2L AMH MAP1A RUNX1 SRCAP RGS14 HEG1 CDK13 AP4M1 FOXI1	5.37e-06	195	188	10	7359_UP
Drug	Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A	ATXN2L ERG MAP1A PER1 GAS7 RUNX1 ARHGAP4 NCOR2 AATK PML	5.37e-06	195	188	10	4124_UP
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	EP400 BCAS3 RBM10 ARHGAP17 PPFIA3 COL18A1 MAST4 ATXN2 KMT2A SRRM2	5.62e-06	196	188	10	2056_DN
Drug	Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	ATXN2L AMH SPHK2 SRCAP HIVEP3 MAST4 FAM120C MARK4 ROBO3 MUC6	5.62e-06	196	188	10	4415_DN
Drug	Nadolol [42200-33-9]; Down 200; 13uM; MCF7; HT_HG-U133A	RUNX1 SRCAP HIVEP3 ARHGAP4 HOXC5 WIZ FAM120C FOXI1 PML BAHCC1	5.62e-06	196	188	10	3359_DN
Drug	Asiaticoside [16830-15-2]; Up 200; 4.2uM; PC3; HT_HG-U133A	RALGAPA1 RNF19B MED14 PPP1R13B SYNPO ZNF467 ZNF358 MARK4 PML BAHCC1	5.88e-06	197	188	10	7244_UP
Drug	Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A	RALGAPA1 SPHK2 DACH1 SRCAP HIVEP3 MARK4 SPEN ENPEP PML BAHCC1	5.88e-06	197	188	10	2259_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	RPS6KA2 RNF19B RUNX1 SRCAP RGS14 HOXC5 SALL2 ZNF358 SRRM2 PML	5.88e-06	197	188	10	3355_DN
Drug	Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A	SPHK2 RPS6KA2 TFDP3 RUNX1 HOXC5 WIZ FAM120C MARK4 PAX2 MYRF	5.88e-06	197	188	10	2817_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ATXN2L FBRS MUC5B RUNX1 FRMD4A HEG1 ADAMTS7 ZNF358 MARK4 MUC6	5.88e-06	197	188	10	4727_UP
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	ATXN2L MAP1A TFDP3 RRP8 NUP214 PRDM2 NCOR2 HEG1 PAX2 ENPEP	6.15e-06	198	188	10	6651_UP
Drug	Ofloxacin [82419-36-1]; Down 200; 11uM; PC3; HT_HG-U133A	PCGF2 BCAS3 RPS6KA2 RNF19B TNS2 RUNX1 SRCAP MAST4 WIZ MYRF	6.15e-06	198	188	10	7372_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	MED14 PPFIA3 HIVEP3 SALL2 WIZ FAM120C FARP1 MARK4 RIPOR1 PML	6.15e-06	198	188	10	4800_DN
Drug	rotenone; Down 200; 1uM; MCF7; HT_HG-U133A	SPHK2 ERG MAP1A FBRS PPFIA3 SCAF4 HEG1 HOXC5 ZNF358 PML	6.15e-06	198	188	10	5943_DN
Drug	Oxantel pamoate [68813-55-8]; Down 200; 6.6uM; PC3; HT_HG-U133A	FBRS PER1 SYNPO RUNX1 PRDM2 ZNF358 MARK4 MYRF CNOT3 PML	6.15e-06	198	188	10	6738_DN
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HG-U133A	RPS6KA2 ZMYND8 MED14 GAS7 PPFIA3 PRDM2 AATK WIZ CDK13 RIPOR1	6.15e-06	198	188	10	121_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; HL60; HT_HG-U133A	PCGF2 RNF19B WASF3 GATA2 RUNX1 ZNF467 CHRNA4 RGS14 SETBP1 MUC6	6.15e-06	198	188	10	2342_UP
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A	RNF19B FBRS PER1 RUNX1 NCOR2 WIZ PER3 ZNF197 PLAGL1 ENPEP	6.15e-06	198	188	10	6992_UP
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	PCGF2 KMT2B MUC5B SCAF4 SLC9A2 FARP1 ZNF197 ULK1 SRRM2 PML	6.15e-06	198	188	10	4592_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	MAP1A GATA2 GAS7 SRCAP COL18A1 RIPOR1 SRRM2 MUC6 GOLGA3 BAHCC1	6.15e-06	198	188	10	7035_UP
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A	SPHK2 RPS6KA2 SYNPO MUC5B NUP214 RUNX1 CDK13 KMT2A RIPOR1 PML	6.43e-06	199	188	10	5085_UP
Drug	CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A	NTN3 RRP8 SRCAP HEYL PTPRN CDK13 MUC2 MUC4 MYRF PML	6.43e-06	199	188	10	6364_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A	NUP214 SCAF4 FRMD4A NCOR2 AATK WIZ ZNF358 MARK4 PAX2 MUC2	6.43e-06	199	188	10	6324_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	MAP1A RPS6KA2 RUNX1 SRCAP HIVEP3 RGS14 MAST4 MARK4 ENPEP PML	6.43e-06	199	188	10	7461_UP
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A	RPS6KA2 RNF19B FBRS DACH1 TNS2 PPFIA3 KDM6B FARP1 RIPOR1 SRRM2	6.43e-06	199	188	10	1702_DN
Drug	Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; PC3; HG-U133A	SPHK2 PCGF2 WASF3 MED14 KDM6B PRDM2 SALL2 ATXN2 FARP1 MARK4	6.43e-06	199	188	10	1911_DN
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	ATXN2L GATA2 TNS2 RUNX1 SRCAP ARHGEF40 HOXC5 CDK13 RIPOR1 PAX2	6.43e-06	199	188	10	7287_UP
Drug	Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A	RPS6KA2 GAS7 NUP214 SRCAP CDK13 MARK4 RIPOR1 ULK1 PML BAHCC1	6.72e-06	200	188	10	7480_UP
Drug	2-propylpentanoic acid; Down 200; 10000uM; HL60; HG-U133A	MXRA5 RBM10 ZMYND8 RUNX1 SRCAP ARHGEF40 SRRM2 PML BAHCC1	2.88e-05	189	188	9	410_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ATXN2L PCGF2 MAP2 PPFIA3 RUNX1 FRMD4A ARHGEF40 WIZ MARK4	3.12e-05	191	188	9	3815_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A	ATXN2L GAS7 MED13L RFX7 COL18A1 ATXN2 FARP1 VGLL4 AP4M1	3.39e-05	193	188	9	455_UP
Drug	Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A	ASXL1 PCGF2 KMT2B ZMYND8 PPFIA3 SALL2 WIZ PLAGL1 RIPOR1	3.39e-05	193	188	9	7232_DN
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MAP1A NUP214 RUNX1 NCOR2 AATK SALL1 WIZ PAX2 PML	3.53e-05	194	188	9	3363_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A	ATXN2L RRP8 MUC5B RUNX1 SCAF4 NCOR2 WIZ ZNF358 PML	3.53e-05	194	188	9	433_DN
Drug	Naringenine [480-41-1]; Down 200; 14.6uM; MCF7; HT_HG-U133A	MUC5B NUP214 RUNX1 SRCAP MAST4 MARK4 SRRM2 MUC6 PML	3.53e-05	194	188	9	4422_DN
Drug	2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A	PCGF2 KMT2B MAP1A MED14 RGS14 NCOR2 HEG1 HOXC5 MARK4	3.67e-05	195	188	9	1214_UP
Drug	Fillalbin [4540-25-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATXN2L PCGF2 TNS2 MAST4 WIZ MARK4 CNOT3 FOXI1 PML	3.67e-05	195	188	9	2813_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ATXN2L RNF19B ZMYND8 NUP214 PPFIA3 SCAF4 MAST4 PLAGL1 SRRM2	3.67e-05	195	188	9	7239_DN
Drug	Nialamide [51-12-7]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ATXN2L KMT2B MAP2 TFDP3 GAS7 TNS2 NCOR2 HOXC5 FAM120C	3.67e-05	195	188	9	3871_DN
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A	SPHK2 ZMYND8 TNS2 NUP214 RUNX1 SLC9A2 ZNF358 ENPEP CNOT3	3.67e-05	195	188	9	4250_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SERPINF1 TNS2 ZNF467 HIVEP3 FRMD4A RGS14 SLC9A2 MARK4 BAHCC1	3.67e-05	195	188	9	2230_DN
Drug	Betulinic acid [472-15-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	RNF19B RUNX1 ARHGAP4 FRMD4A MAST4 WIZ SETBP1 SYT5 FOXI1	3.67e-05	195	188	9	4181_DN
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	MAP1A RPS6KA2 CHRNA4 RGS14 NCOR2 PTPRN SRRM2 FOXI1 PML	3.67e-05	195	188	9	4424_UP
Drug	Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A	PER1 MUC5B NUP214 RUNX1 SRCAP ARHGAP4 CDK13 PLAGL1 PML	3.67e-05	195	188	9	2875_UP
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; HL60; HT_HG-U133A	MAGEA12 ERG RUNX1 CHRNA4 HEG1 FARP1 MUC2 MYRF ENPEP	3.82e-05	196	188	9	6158_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	ATXN2L DACH1 PPFIA3 SRCAP HIVEP3 FRMD4A CDK13 MARK4 PML	3.82e-05	196	188	9	3872_DN
Drug	3-nitropropionic acid; Down 200; 10uM; MCF7; HT_HG-U133A	RPS6KA2 NTN3 RRP8 RUNX1 HEYL PTPRN MUC2 MYRF PML	3.82e-05	196	188	9	6367_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SPHK2 MXRA5 PCGF2 RPS6KA2 PPFIA3 PLAGL1 MUC2 PML BAHCC1	3.82e-05	196	188	9	2784_UP
Drug	(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A	ATXN2L AMH MAGEA12 SERPINF1 GAS7 RUNX1 HIVEP3 KMT2A PML	3.82e-05	196	188	9	6053_UP
Drug	Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A	ATXN2L SPHK2 PCGF2 MED14 CCDC88C WIZ ADAMTS7 FARP1 SETBP1	3.82e-05	196	188	9	2988_UP
Drug	Fenspiride hydrochloride [5053-08-7]; Down 200; 13.4uM; PC3; HT_HG-U133A	FAM193B PCGF2 RPS6KA2 RNF19B PPFIA3 SRCAP SCAF4 SRRM2 CNOT3	3.82e-05	196	188	9	7298_DN
Drug	Gabazine [105538-73-6]; Down 200; 10.8uM; PC3; HT_HG-U133A	PCGF2 ZMYND8 PPFIA3 RGS14 SLC9A2 FAM120C ENPEP CNOT3 PML	3.82e-05	196	188	9	4236_DN
Drug	6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A	ATXN2L MAP1A SERPINF1 MED14 SRCAP WIZ PLAGL1 RIPOR1 PAX2	3.82e-05	196	188	9	7346_UP
Drug	Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A	RPS6KA2 ZMYND8 TNS2 RUNX1 SRCAP RGS14 MARK4 PML BAHCC1	3.82e-05	196	188	9	5757_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	RALGAPA1 PER1 RUNX1 SRCAP PRDM2 HIVEP3 LIPE AATK CDK13	3.82e-05	196	188	9	4750_UP
Drug	Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A	PCGF2 RUNX1 PRDM2 HIVEP3 FRMD4A RGS14 WIZ ZNF358 PML	3.82e-05	196	188	9	3816_DN
Drug	Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A	SPHK2 MUC5B RUNX1 HIVEP3 HEG1 PER3 ROBO3 PML BAHCC1	3.82e-05	196	188	9	4407_DN
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A	SPHK2 GAS7 SYNPO PRDM2 ARHGEF40 MAST4 ADAMTS7 PAX2 PML	3.82e-05	196	188	9	5109_UP
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	AMH SERPINF1 ZMYND8 PER1 NUP214 SRCAP HOXC5 ZNF197 PAX2	3.98e-05	197	188	9	2324_UP
Drug	Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A	MAP2 ZMYND8 RUNX1 RGS14 NCOR2 CDK13 KMT2A PAX2 ENPEP	3.98e-05	197	188	9	4266_UP
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A	ATXN2L KMT2B SYNPO MUC5B NUP214 RUNX1 KDM6B ARHGEF40 BAHCC1	3.98e-05	197	188	9	6311_UP
Drug	Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A	MAP1A RNF19B PER1 RUNX1 CDK13 ZNF358 MYRF PML BAHCC1	3.98e-05	197	188	9	4295_DN
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	ATXN2L SPHK2 PPFIA3 CCDC88C FRMD4A NCOR2 SETD2 MAST4 ENPEP	3.98e-05	197	188	9	4764_DN
Drug	Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A	NUP214 RUNX1 HIVEP3 RGS14 ADAMTS7 MARK4 KMT2A PAX2 PML	3.98e-05	197	188	9	6055_UP
Drug	N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A	BCAS3 GATA2 PER1 NUP214 RUNX1 KDM6B NCOR2 MAST4 PML	3.98e-05	197	188	9	6732_DN
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A	ERG MAP1A SYNPO RRP8 RUNX1 HIVEP3 NRXN2 MARK4 PAX2	3.98e-05	197	188	9	3617_UP
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A	NACA MUC5B PPFIA3 RUNX1 ZNF467 RGS14 SLC9A2 ZNF358 ZNF197	3.98e-05	197	188	9	1219_UP
Drug	Ajmaline [4360-12-7]; Up 200; 12.2uM; HL60; HG-U133A	FBRS PER1 NPDC1 NUP214 COL18A1 HEG1 SALL2 WIZ ATXN2	3.98e-05	197	188	9	1749_UP
Drug	aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A	ATXN2L RNF19B FBRS PER1 SETD2 MAST4 RIPOR1 AP4M1 PML	3.98e-05	197	188	9	5201_DN
Drug	Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A	SPHK2 MED14 GAS7 NUP214 RUNX1 SRCAP ZNF358 MUC6 PML	3.98e-05	197	188	9	3413_UP
Drug	Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A	ERG SERPINF1 ZMYND8 DACH1 RUNX1 SRCAP RGS14 MARK4 PML	3.98e-05	197	188	9	5499_UP
Drug	Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; PC3; HT_HG-U133A	MAP1A KIF26B RUNX1 CHRNA4 NCOR2 WIZ TOX3 PAX2 ENPEP	3.98e-05	197	188	9	6642_UP
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B RFX7 SETD2 SRRM2 MED13	4.79e-08	17	181	5	DOID:0060307 (is_implicated_in)
Disease	Intellectual Disability	RALGAPA1 CACNA1B PCGF2 PTPN23 MED13L KDM6B CHAMP1 COL18A1 SETD2 NRXN2 SETBP1 AP4M1 MED13 HTT	7.64e-07	447	181	14	C3714756
Disease	Myeloid Leukemia, Chronic	ASXL1 PER1 RUNX1 PER3 SETBP1	8.66e-07	29	181	5	C0023473
Disease	hematocrit	RALGAPA1 ERG NUMBL BCAS3 PPP1R13B SYNPO RUNX1 RBBP8NL PPARGC1A FRMD4A RGS14 NCOR2 ARHGEF40 SALL1 PNPLA1 ATXN2 MARK4 TOX3 NYAP1 MYRF BAHCC1	1.17e-06	1011	181	21	EFO_0004348
Disease	Neurodevelopmental Disorders	MED13L SRCAP CDC42BPB HIVEP3 SETD2 SETBP1 KMT2A	1.77e-06	93	181	7	C1535926
Disease	red blood cell density measurement	RALGAPA1 ERG EP400 BCAS3 RUNX1 RBBP8NL KDM6B RFX7 PPARGC1A FRMD4A RGS14 ZNF106 ARHGEF40 SALL1 PNPLA1 ATXN2 MARK4 MUC4 MYRF	2.23e-06	880	181	19	EFO_0007978
Disease	mucinous adenocarcinoma (is_marker_for)	MUC2 MUC4 MUC6	2.25e-06	5	181	3	DOID:3030 (is_marker_for)
Disease	Juvenile Myelomonocytic Leukemia	ASXL1 GATA2 RUNX1 SETBP1	4.94e-06	19	181	4	C0349639
Disease	neuroimaging measurement	ZNF438 ATXN2L KMT2B MAP2 KIF26B FGFRL1 FAF1 CCDC88C DNAAF3 PPARGC1A COL18A1 ZNF106 MAST4 ATXN2 TOX3 PKD1 ROBO3 HTT BAHCC1	3.42e-05	1069	181	19	EFO_0004346
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ERG NUP214 RUNX1 SETD2 KMT2A	3.70e-05	61	181	5	C1961102
Disease	spinocerebellar ataxia type 2 (implicated_via_orthology)	ATXN2L ATXN2	3.74e-05	2	181	2	DOID:0050955 (implicated_via_orthology)
Disease	pulse pressure measurement	ZNF438 CD164L2 AMH MXRA5 ERG COL27A1 SYNPO2L GATA2 ZCCHC2 MED13L KDM6B SRCAP FAF1 HIVEP3 PPARGC1A TTBK1 CEP120 KIAA1217 PKD1 PAX2 ROBO3 ENPEP	4.71e-05	1392	181	22	EFO_0005763
Disease	eosinophil percentage of leukocytes	KMT2B ERG ZMYND8 RUNX1 KDM6B HIVEP3 RGS14 SETD2 SALL1 ATXN2 IFITM3 MARK4 UNK MUC2 TOX2	6.14e-05	746	181	15	EFO_0007991
Disease	QRS duration	TCF12 NACA GAS7 FAF1 PPARGC1A ZNF358 SETBP1 KMT2A MYRF	1.00e-04	298	181	9	EFO_0005055
Disease	Leukemia, Myelocytic, Acute	ERG GATA2 NUP214 RUNX1 SETD2 SETBP1 KMT2A	1.01e-04	173	181	7	C0023467
Disease	primary angle-closure glaucoma (is_implicated_in)	COL18A1 MYRF	1.12e-04	3	181	2	DOID:1405 (is_implicated_in)
Disease	testosterone measurement	ZNF438 ATXN2L ZNF703 TCF12 MAP1A TPRN DACH1 FGFRL1 KDM6B SRCAP CHAMP1 FAF1 RGS14 NCOR2 ARHGEF40 TTBK1 LIPE CEP120 PER3 PLAGL1	1.18e-04	1275	181	20	EFO_0004908
Disease	eosinophil count	ERG ZMYND8 RUNX1 KDM6B NACAD HIVEP3 RGS14 NCOR2 SETD2 SLC9A2 SALL1 ATXN2 IFITM3 MARK4 SEC16A UNK CD300LG PLAGL1 MUC2 TOX2 MYRF BAHCC1	1.24e-04	1488	181	22	EFO_0004842
Disease	Acute myeloid leukemia	GATA2 NUP214 RUNX1	1.45e-04	17	181	3	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	GATA2 NUP214 RUNX1	1.45e-04	17	181	3	601626
Disease	brain measurement, neuroimaging measurement	ZNF438 ATXN2L MAP2 KIF26B DSCAML1 FAF1 CCDC88C DNAAF3 COL18A1 MAST4 TOX3 BAHCC1	1.61e-04	550	181	12	EFO_0004346, EFO_0004464
Disease	aortic measurement	NUMBL GATA2 KANK2 HIVEP3 COL18A1 ARHGEF40 CEP120 ADAMTS7	1.69e-04	251	181	8	EFO_0020865
Disease	acute myeloid leukemia (is_implicated_in)	ASXL1 GATA2 NUP214 RUNX1 KMT2A	1.71e-04	84	181	5	DOID:9119 (is_implicated_in)
Disease	serum gamma-glutamyl transferase measurement	AMH MAP1A CDC42BPB FAF1 NCOR2 SETD2 SLC9A2 SALL1 CEP120 PKD1 KMT2A PAX2 ULK1 MUC6 MED13 BAHCC1	1.73e-04	914	181	16	EFO_0004532
Disease	chronic kidney disease (is_marker_for)	SYNPO SALL1 PAX2	2.40e-04	20	181	3	DOID:784 (is_marker_for)
Disease	L2 Acute Lymphoblastic Leukemia	ERG NUP214 RUNX1 KMT2A	2.53e-04	50	181	4	C0023453
Disease	platelet crit	ERG MAP1A BCAS3 GATA2 DACH1 RUNX1 KDM6B KRBA1 SLC9A2 ARHGEF40 MAST4 ATXN2 CDK13 MARK4 SYT5 UBALD1	2.73e-04	952	181	16	EFO_0007985
Disease	mean arterial pressure	ERG SYNPO2L TNS2 HIVEP3 TTBK1 ATXN2 KIAA1217 MARK4 PAX2 ENPEP BAHCC1	2.77e-04	499	181	11	EFO_0006340
Disease	Childhood Acute Lymphoblastic Leukemia	ERG NUP214 RUNX1 KMT2A	2.95e-04	52	181	4	C0023452
Disease	leukemia	ERG SETD2 KMT2A TOP2A	3.66e-04	55	181	4	C0023418
Disease	mucositis (biomarker_via_orthology)	MUC2 MUC4	3.70e-04	5	181	2	DOID:0080178 (biomarker_via_orthology)
Disease	Myelodysplastic syndrome	ASXL1 GATA2	3.70e-04	5	181	2	cv:C3463824
Disease	MYELODYSPLASTIC SYNDROME	ASXL1 GATA2	3.70e-04	5	181	2	614286
Disease	obesity (implicated_via_orthology)	SPHK2 TCF12 MED13L PPARGC1A PNPLA1 SEC16A MED13	3.81e-04	215	181	7	DOID:9970 (implicated_via_orthology)
Disease	Adenoid Cystic Carcinoma	SERPINF1 KDM6B SRCAP SETD2 TOP2A	3.86e-04	100	181	5	C0010606
Disease	Alzheimer's disease (implicated_via_orthology)	MAP2 SERPINF1 HIVEP3 PPARGC1A	4.20e-04	57	181	4	DOID:10652 (implicated_via_orthology)
Disease	sexual dimorphism measurement	RALGAPA1 ATXN2L KMT2B PTPN23 FAF1 HEYL NCOR2 ARHGEF40 CEP120 PNPLA1 CASKIN1 PKD1 SEC16A CD300LG PAX2 MYRF FUBP3	4.90e-04	1106	181	17	EFO_0021796
Disease	cortical thickness	ZNF438 KMT2B RPS6KA2 FGFRL1 GAS7 FAF1 DNAAF3 COL18A1 ZNF106 ARHGEF40 CEP120 MAST4 ADAMTS7 ATXN2 TOX3 PKD1 KMT2A	5.26e-04	1113	181	17	EFO_0004840
Disease	monocyte percentage of leukocytes	ERG GATA2 NPDC1 MED13L RUNX1 KDM6B SETD2 WIZ ATXN2 MARK4 SEC16A PLAGL1 BAHCC1	6.13e-04	731	181	13	EFO_0007989
Disease	cortical surface area measurement	ZNF438 ATXN2L TICRR MAP2 KIF26B FGFRL1 RCSD1 MED13L FAF1 CCDC88C DNAAF3 ZNF106 CEP120 MAST4 ADAMTS7 ATXN2 TOX3 PKD1 PAX2	6.40e-04	1345	181	19	EFO_0010736
Disease	cholangiocarcinoma (is_marker_for)	MUC5B MUC2 MUC4 MUC6	6.53e-04	64	181	4	DOID:4947 (is_marker_for)
Disease	rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement	ZNF438 KMT2B RUNX1 HIVEP3 ATXN2 MYRF	6.55e-04	170	181	6	EFO_0000685, EFO_0007791, EFO_0007837
Disease	longevity, healthspan, parental longevity	ATXN2 TOX3 HTT	7.38e-04	29	181	3	EFO_0004300, EFO_0007796, EFO_0009762
Disease	Hematopoetic Myelodysplasia	ASXL1 GATA2 RUNX1	7.38e-04	29	181	3	C2713368
Disease	basophil count, eosinophil count	ERG RUNX1 KDM6B HIVEP3 ATXN2 MARK4 UNK	7.50e-04	241	181	7	EFO_0004842, EFO_0005090
Disease	Developmental regression	CACNA1B NUP214	7.70e-04	7	181	2	C1836830
Disease	MYELODYSPLASTIC SYNDROME	ASXL1 GATA2 RUNX1 SETBP1	7.77e-04	67	181	4	C3463824
Disease	lymphocyte measurement	BCAS3 NPDC1 RFX7 ATXN2 ULK1	7.91e-04	117	181	5	EFO_0803546
Disease	adult onset asthma	RUNX1 SLC9A2 PLAGL1 MUC2 MYRF	8.22e-04	118	181	5	EFO_1002011
Disease	lymphocyte percentage of leukocytes	SPHK2 TENT4B ERG GATA2 RFX7 FAF1 SETD2 AATK ATXN2 CDK13 MARK4 PLAGL1	8.74e-04	665	181	12	EFO_0007993
Disease	Large cell carcinoma of lung	CDC42BPB TTBK1 BRSK1	9.88e-04	32	181	3	C0345958
Disease	Malignant neoplasm of breast	ZNF438 AVPR2 MED14 PER1 NUP214 HEYL SETD2 SLC9A2 LIPE PER3 FARP1 SETBP1 TOX3 SPEN ENPEP TOP2A	9.98e-04	1074	181	16	C0006142
Disease	myelofibrosis (is_implicated_in)	ASXL1 KMT2A	1.02e-03	8	181	2	DOID:4971 (is_implicated_in)
Disease	triacylglycerol 58:6 measurement	HIVEP3 TOX3	1.02e-03	8	181	2	EFO_0010440
Disease	tumor necrosis factor receptor II measurement	RGS14 ATXN2	1.02e-03	8	181	2	EFO_0008384
Disease	Acute Myeloid Leukemia, M1	ERG GATA2 NUP214 RUNX1 KMT2A	1.06e-03	125	181	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	ERG GATA2 NUP214 RUNX1 KMT2A	1.06e-03	125	181	5	C1879321
Disease	nephroblastoma (is_marker_for)	SERPINF1 PAX2 TOP2A	1.18e-03	34	181	3	DOID:2154 (is_marker_for)
Disease	ulcerative colitis (biomarker_via_orthology)	COL18A1 MUC2	1.31e-03	9	181	2	DOID:8577 (biomarker_via_orthology)
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	MUC5B SETD2	1.31e-03	9	181	2	DOID:0050156 (is_implicated_in)
Disease	bitter alcoholic beverage consumption measurement	PPP1R13B KDM6B NRXN2 PAX2 BAHCC1	1.40e-03	133	181	5	EFO_0010092
Disease	neutrophil percentage of leukocytes	SPHK2 GATA2 FAF1 SETD2 AATK ATXN2 CDK13 MARK4 PLAGL1 TOP2A HTT	1.44e-03	610	181	11	EFO_0007990
Disease	Prostatic Neoplasms	ERG SERPINF1 WASF3 RUNX1 SETD2 KMT2A SPEN MUC4 CNOT3 TOP2A PML	1.55e-03	616	181	11	C0033578
Disease	Malignant neoplasm of prostate	ERG SERPINF1 WASF3 RUNX1 SETD2 KMT2A SPEN MUC4 CNOT3 TOP2A PML	1.55e-03	616	181	11	C0376358
Disease	renal Wilms' tumor (is_implicated_in)	SALL1 PAX2	1.63e-03	10	181	2	DOID:5176 (is_implicated_in)
Disease	otitis media (is_marker_for)	MUC5B MUC4	1.63e-03	10	181	2	DOID:10754 (is_marker_for)
Disease	allergic conjunctivitis (is_marker_for)	MUC2 MUC4	1.63e-03	10	181	2	DOID:11204 (is_marker_for)
Disease	Profound Mental Retardation	MED13L KDM6B COL18A1 SETBP1 AP4M1	1.70e-03	139	181	5	C0020796
Disease	Mental Retardation, Psychosocial	MED13L KDM6B COL18A1 SETBP1 AP4M1	1.70e-03	139	181	5	C0025363
Disease	Mental deficiency	MED13L KDM6B COL18A1 SETBP1 AP4M1	1.70e-03	139	181	5	C0917816
Disease	total blood protein measurement	ZNF438 RUNX1 NCOR2 SETD2 ATXN2 MARK4 PKD1 SEC16A FUBP3	1.90e-03	449	181	9	EFO_0004536
Disease	chronic kidney disease, Proteinuria	GAS7 KMT2A	1.98e-03	11	181	2	EFO_0003884, HP_0000093
Disease	left ventricular structural measurement	RUNX1 FAF1 ATXN2 ZNF358	2.14e-03	88	181	4	EFO_0008205
Disease	neutrophil count	SPHK2 ERG GATA2 RCSD1 ZCCHC2 KDM6B MSTO1 HIVEP3 SETD2 AATK SALL1 ATXN2 MARK4 PKD1 PLAGL1 TOX2 MYRF HTT	2.19e-03	1382	181	18	EFO_0004833
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	ATXN2L ATXN2	2.37e-03	12	181	2	DOID:1441 (implicated_via_orthology)
Disease	acute myeloid leukemia (implicated_via_orthology)	KMT2A TOP2A	2.37e-03	12	181	2	DOID:9119 (implicated_via_orthology)
Disease	lean body mass	PPFIA2 FAF1 NCOR2 ARHGEF40 AATK CEP120 VGLL4 PML	2.46e-03	379	181	8	EFO_0004995
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	ZNF106 ATXN2 SEC16A CD300LG MYRF HTT	2.56e-03	222	181	6	EFO_0008317, EFO_0020943
Disease	myeloid leukemia (is_implicated_in)	ERG GATA2	2.79e-03	13	181	2	DOID:8692 (is_implicated_in)
Disease	colitis (implicated_via_orthology)	PPARGC1A MUC2	2.79e-03	13	181	2	DOID:0060180 (implicated_via_orthology)
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	MYRF CNOT3	2.79e-03	13	181	2	OBA_2045159
Disease	methylcobalamin deficiency type cblE, response to antineoplastic agent	GAS7 KMT2A	2.79e-03	13	181	2	GO_0097327, MONDO_0009354
Disease	unipolar depression, bipolar disorder	WASF3 ZMYND8 RTN1 STARD9 SETBP1	2.81e-03	156	181	5	EFO_0003761, MONDO_0004985
Disease	Acute Promyelocytic Leukemia	ASXL1 FIP1L1 PML	2.84e-03	46	181	3	C0023487
Disease	cryptic phenotype measurement	BCAS3 CHRNA4 ATXN2	3.02e-03	47	181	3	EFO_0021487
Disease	Salivary Gland Neoplasms	SERPINF1 SPEN TOP2A	3.02e-03	47	181	3	C0036095
Disease	phosphoglycerides measurement	KANK2 NCOR2 CD300LG	3.21e-03	48	181	3	EFO_0022291
Disease	inositol measurement	ARHGAP17 SETBP1	3.24e-03	14	181	2	EFO_0010504
Disease	diacylglycerol 38:4 measurement	MYRF CNOT3	3.24e-03	14	181	2	EFO_0020066
Disease	eosinophil percentage of granulocytes	RUNX1 KDM6B HIVEP3 ATXN2 IFITM3 PLAGL1	3.31e-03	234	181	6	EFO_0007996
Disease	developmental disorder of mental health (implicated_via_orthology)	TCF12 SRCAP NCOR2	3.40e-03	49	181	3	DOID:0060037 (implicated_via_orthology)
Disease	creatinine measurement	TCF12 KIF26B BCAS3 PPFIA2 DACH1 PPARGC1A COL18A1 RGS14 SLC9A2 NRXN2 ADAMTS7 IFITM3 SETBP1 FIP1L1	3.44e-03	995	181	14	EFO_0004518
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	NCOR2 ATXN2 SEC16A CD300LG MYRF HTT	3.68e-03	239	181	6	EFO_0008317, EFO_0020945
Disease	Hypermetropia	DSCAML1 HIVEP3 CCDC88C MARK4	3.78e-03	103	181	4	HP_0000540
Disease	alkaline phosphatase measurement	RALGAPA1 MAP1A NUMBL FGFRL1 RUNX1 KIAA0319 HIVEP3 ATXN2 IFITM3 CASKIN1 MARK4 PKD1 MYRF FUBP3	4.09e-03	1015	181	14	EFO_0004533
Disease	handedness	ATXN2L MAP2 WASF3 VGLL4	4.18e-03	106	181	4	EFO_0009902
Disease	QRS-T angle	NACA GAS7 FARP1 KMT2A	4.18e-03	106	181	4	EFO_0020097
Disease	teratocarcinoma-derived growth factor 1 measurement	GAS7 KMT2A	4.24e-03	16	181	2	EFO_0008297
Disease	Cardiovascular Abnormalities	PCGF2 GATA2	4.24e-03	16	181	2	C0243050
Disease	vitamin C measurement	BCAS3 RGS14	4.24e-03	16	181	2	EFO_0600003

Protein segments in the cluster

Peptide	Gene	Start	Entry
GTFRNSPISHPPSPS	AHRR	446	A9YTQ3
PSTHPPRTAAPTTAS	EP400	1481	Q96L91
EPPATSGTQSLHPPS	CHRNA4	391	P43681
ASTHPSGPSSSPPEQ	BAHCC1	86	Q9P281
AASGPPSTVPLPHSS	BAHCC1	1316	Q9P281
PHPGSSTPTLASRGI	ARHGEF40	1486	Q8TER5
VAPHPPALPVTSSSF	ERG	431	P11308
SGPSPTARSGPHLSA	CLK3	21	P49761
SPFHSPPSTPSSPGV	RCSD1	116	Q6JBY9
PVPGLSSSPSGSPLH	BCAS3	481	Q9H6U6
ATSSPAPSIGPPASS	DACH1	36	Q9UI36
GTHLCSTTPDRPPPS	CACNA1B	2031	Q00975
PKPSLSSHPTSPTAG	CACNA1B	2141	Q00975
SDPSTGPESTHPLPA	CDK13	1441	Q14004
SGSTSPSPLPFLHGS	PPP1R13B	616	Q96KQ4
TDPAGLSSPHLPGTS	ASXL1	456	Q8IXJ9
HPAAPSTGSPVPATE	ADAMTS7	1101	Q9UKP4
PSSTLPPLSPVGSTH	ADAMTS7	1236	Q9UKP4
PPLSPVGSTHSSPSP	ADAMTS7	1241	Q9UKP4
TPTSPGPRTHSTPSI	ATXN2L	681	Q8WWM7
PGPPSHGLSTSASPL	AP4M1	386	O00189
KASPAPSHNSGTPAP	CNOT3	356	O75175
PAQPGHVSPTPATTS	NUMBL	256	Q9Y6R0
HPSSRTTESPPSPGT	MUC5B	2256	Q9HC84
TTESPPSPGTTTPGH	MUC5B	2261	Q9HC84
SPPSPGTTTPGHTRA	MUC5B	2821	Q9HC84
TPSSALGTTHTPPVP	MUC5B	3991	Q9HC84
TESPPSPGTTTPGHT	MUC5B	4076	Q9HC84
SPTHPSSALPPATSP	RBM10	541	P98175
QSPSPRSSHGSPPTL	HJV	6	Q6ZVN8
GPSSAGQSTPSPHLV	PTPN23	1071	Q9H3S7
PSASSSPHPSAAVPA	TENT4B	51	Q8NDF8
VSTGHATPLPVTSPS	MUC4	1001	Q99102
TIPSAASTGHTTPLP	MUC4	1236	Q99102
GHATPLPVTIPSSVS	MUC4	3836	Q99102
TGPSPSSNHTPASPT	MUC6	1236	Q6W4X9
NHSAPTGTIPPPTTL	MUC6	1476	Q6W4X9
PPTTLKATGSTHTAP	MUC6	1486	Q6W4X9
SRLPTPFTTHSPPTG	MUC6	1791	Q6W4X9
PFTTHSPPTGTTPIS	MUC6	1796	Q6W4X9
RLPTPFTTHSPPTGS	MUC6	1961	Q6W4X9
ASIHSTPTGTVPPPT	MUC6	2036	Q6W4X9
PLSPGGPTHLTKPTT	NCOR2	1776	Q9Y618
VGPTTEKPSSHLPPT	CASKIN1	671	Q8WXD9
SITFPPPAPSNSLHG	HOXC5	46	Q00444
SPMPGHPTASPTSSE	PTPRN	406	Q16849
PDGPTSQPHLATTPT	KRBA1	121	A5PL33
PEPHAATASPPTDGT	MAP1A	1256	P78559
NLHSSPNSSPVPSPG	MED13L	2046	Q71F56
ADSPSPPHSPQGASS	MAGEA2	56	P43356
AESPSPPHSPQGAST	MAGEA12	56	P43365
PPHSPQGASTLPTTI	MAGEA12	61	P43365
ETPLPSPTASPGHSP	GPR162	511	Q16538
VLGAPHNPAPPTSTV	IFITM3	31	Q01628
SPSPPSSGHSTPRLA	PPFIA3	666	O75145
SSGHSTPRLAPPSPA	PPFIA3	671	O75145
PSHPSAHGSPAPVST	ATXN2	596	Q99700
AAPAHSPSPASPRSV	KIF26B	1011	Q2KJY2
GTQDSHTPPTPPTPT	KDM6B	536	O15054
PVPPASHAPASRSAS	CCDC88C	1786	Q9P219
TPAEGPPTPASHSPS	PER1	941	O15534
PSHPTATVLSTGSPP	PER3	1036	P56645
PPGPPVASSSSATSL	FGFRL1	361	Q8N441
PTAPTTTSGGHTLSP	MUC2	4256	Q02817
HTSQLTPGTPPPSAL	MSTO1	426	Q9BUK6
TPGTPPPSALHACTT	MSTO1	431	Q9BUK6
HTTEAGTLPAPTPSP	COL18A1	181	P39060
APGTPASHSATPSLL	KAT14	336	Q9H8E8
PSPAHSSSPGKPSDF	DBX1	311	A6NMT0
PPSLIPTIESGHSSG	FIP1L1	401	Q6UN15
NPHSTPVSGPPAFLT	FUBP3	471	Q96I24
AVSAEPPTTLPGTHP	TCF12	656	Q99081
PPTTLPGTHPGLSET	TCF12	661	Q99081
TSAPGFPHLPTANPT	NRXN2	1601	Q9P2S2
AVHKPPSSTPGSSLP	PNPLA1	376	Q8N8W4
HSQAPTSPRPSLGPS	PNPLA1	416	Q8N8W4
SKPAASGPLSHPTPL	NUP214	616	P35658
CDEASPTPSSHPTPG	GPR152	426	Q8TDT2
HIAPLLQSSSPTPPG	HEYL	271	Q9NQ87
PSPGSPSSLTHHIPT	KMT2B	1886	Q9UMN6
TTGDPAPLHDPTSAP	AMH	356	P03971
SLPPTGPPSTPASHA	LILRA6	426	Q6PI73
PGTAPAPSHLPSSTA	ENPEP	51	Q07075
APSHLPSSTASPSGP	ENPEP	56	Q07075
SSGPPLPLPSVSQSH	HEG1	671	Q9ULI3
HSTPSNSSNPSGPPS	CDC42BPB	1676	Q9Y5S2
SHSGPSSLPEAPLKP	GOLGA3	16	Q08378
KHSPTSEPTPPGDAL	EPS8L2	461	Q9H6S3
PGHTIVPSTASPPVS	PAX2	161	Q02962
SPASFVPTPPPSSHG	MED14	1061	O60244
HGSNPSTPAATPVPT	PROSER1	271	Q86XN7
PTSPTPSAFKGPSHS	PROSER1	611	Q86XN7
LPPHGSSTPIAPVFT	PROSER1	681	Q86XN7
STPGTPTPTPHTSLG	NPDC1	146	Q9NQX5
PTPTPHTSLGSPVSS	NPDC1	151	Q9NQX5
TAGLTPPTTPPHKAN	PPARGC1A	291	Q9UBK2
LPSPATPSHGSPSSH	PCGF2	276	P35227
HPTSPTPPSTASGAT	PCGF2	296	P35227
HSPALLTSPGGTASP	NTN3	76	O00634
HTASPEPPTQSGPLT	RBBP8NL	471	Q8NC74
PTPIHPSSSLSFGHP	GATA2	456	P23769
PSSEIGATPPSSPHH	FRMD4A	996	Q9P2Q2
AAAPGTPHLLSKTPP	FBRS	416	Q9HAH7
LSPSPPVSSHPLDGD	HTT	2071	P42858
PVGNSPALASSHPVP	E2F8	711	A0AVK6
PGTPAAPTPESFTVH	DNAAF3	346	Q8N9W5
HPCTPASTTVIPGTP	EFCAB6	1291	Q5THR3
TGPKSPTVSPVPSHN	CEP120	376	Q8N960
PTPSHTGSPDPEQAS	COL20A1	136	Q9P218
PQPASLIPSHPSSFG	FAM193B	256	Q96PV7
PPQPSTGSLTGSPHL	FARP1	466	Q9Y4F1
PHPGAPAAASTATLP	DSCAML1	1956	Q8TD84
SHFPETLGPPSASSP	CHAMP1	231	Q96JM3
PSKASPPLGPDSSHS	FAM120C	511	Q9NX05
PLSSRSAPASPTHPG	FOXK1	411	P85037
PASARTSTHKPPPFT	COL27A1	471	Q8IZC6
LHTPRASPTGTPGTT	BRSK1	521	Q8TDC3
PASPSSHSLAPPSGE	MARK4	541	Q96L34
SLPGSPTHSLSPRSP	MAST4	1296	O15021
SSGLSTPVPPSAGHL	KANK2	171	Q63ZY3
PLPSAGSPTPTTHEI	KMT2A	2161	Q03164
TGRTHSSPPRAPSSP	HEPACAM	371	Q14CZ8
TVTTGSPPVPEAHSP	CD164L2	121	Q6UWJ8
TPDLPPPSSSSHAGA	FAF1	171	Q9UNN5
SHPLVTPGLSPEPSD	FOXI1	296	Q12951
ASTPAAPSPVGSSSP	GJA3	346	Q9Y6H8
APSPVGSSSPPLAHE	GJA3	351	Q9Y6H8
PDSQKPPTHPGTSDS	DCBLD1	681	Q8N8Z6
TPPSTTVGSHSPPET	ZMYND8	746	Q9ULU4
PHTPPISIPNSTIAG	SCAF4	756	O95104
APIPISHSATSPPGS	SALL1	576	Q9NSC2
HSNPPDSGSSVPTDP	SALL2	96	Q9Y467
TVTISPPLAHTGPGP	LIPE	586	Q05469
SSPPSGHSTPKLTPR	PPFIA2	716	O75334
PTVPLPAPSSSASPH	PRDM2	991	Q13029
PPPSAGSDASHPSTS	PKD1	4176	P98161
GGPTELTPATSHPLT	OTOG	1941	Q6ZRI0
TSSRPPVPGKTSPHG	NYAP1	501	Q6ZVC0
SPSVHPATPISPGRA	RUNX1	266	Q01196
GPPTIPSPLDHEASS	RTN1	391	Q16799
SSAVGPPDHTSDPPS	SAP25	161	Q8TEE9
PSPDTPPDSSRISHG	SYT5	11	O00445
TPLPSFTSGVPSHAP	SYNPO2L	516	Q9H987
PSHAPVSGSPSTPRS	SYNPO2L	526	Q9H987
SLASLHPSVSPGSPP	PLAGL1	281	Q9UM63
PSTPRAQGAPSPSAH	RNF19B	696	Q6ZMZ0
PETPPRQSHSGSISP	SRRM2	981	Q9UQ35
APPGVVPVLSAHSPS	AATK	511	Q6ZMQ8
SSGTSQHPPSLSPKP	ARHGAP17	656	Q68EM7
SLSSTSLPEPGPPRH	SYNPO	216	Q8N3V7
PSTSKAVSPPHLDGP	PML	511	P29590
SPGIPASPGSHRSSL	GAS7	111	O60861
SHLPTLGSKTPPASP	KIAA1217	461	Q5T5P2
SPQTGPPAHSASLIP	KIAA1217	1841	Q5T5P2
HSTLSASGPPEPLLP	SPATA31E1	216	Q6ZUB1
VHPDLGPNPSSKPTS	WHAMM	756	Q8TF30
SPLGHSPTASPPPTA	WIZ	1146	O95785
SQPPVSSVSHAPPGV	SEC31B	1036	Q9NQW1
VSSPSPSSPHSPGLF	STARD9	3856	Q9P2P6
PSSPHSPGLFPSTSE	STARD9	3861	Q9P2P6
PQSDIPTPSPVGSTH	MED13	286	Q9UHV7
TISSPLHVPSSLPGP	SRCAP	1396	Q6ZRS2
PASPVGPAPAHTLTL	SRCAP	1756	Q6ZRS2
GPAPAHTLTLAPASS	SRCAP	1761	Q6ZRS2
PSASHPQGLDTTPKP	ARHGAP4	931	P98171
SNTPGAPETHPSSSP	ANKHD1	2056	Q8IWZ3
TSPHPATSPPAGSSR	CD300LG	201	Q6UXG3
PTPTPTPDKSHNSGV	CLCA4	881	Q14CN2
PVASALSSHRTGPPP	VGLL4	36	Q14135
PGPAPSPSPALTHST	ZCCHC2	966	Q9C0B9
TLGSSHCSATPAPPP	PIAS3	576	Q9Y6X2
PFPPHGAPVSASSSS	ZNF703	201	Q9H7S9
SAPGTTLPPVLPGSH	ZNF197	146	O14709
AEKSSLSHPGIPPSP	TICRR	1496	Q7Z2Z1
ACTPTHGPSSTPSPF	TICRR	1646	Q7Z2Z1
RSETSQPPTPGSPSH	TTBK1	626	Q5TCY1
SPLDPGHSSVHPTPA	ZP1	181	P60852
PVHSPLGSRSQTPSP	RALGAPA1	991	Q6GYQ0
PGPSSFPRASHPSST	SPEN	3031	Q96T58
TTSGPSTPPGLVLPH	SPEN	3461	Q96T58
TTPSPGLQPAHLTFP	SERPINF1	371	P36955
PHDGVVTPAASPSLP	SEC16A	191	O15027
LSSPPGSPKAALHSP	SPHK2	471	Q9NRA0
SSSPPSPASVVAPGT	SLC9A2	46	Q9UBY0
ASPHLSPSPAPSTAS	ROBO3	1211	Q96MS0
SSTHAAPPHPPSTGL	WASF3	376	Q9UPY6
RSPSCSPGPAHPLSS	HIVEP3	2141	Q5T1R4
TGAPAEPTPTHSPCT	HIVEP3	2296	Q5T1R4
LEPSSPSPLGTAPHT	NMB	61	P08949
SPGSTSPKPPHTLSR	RRP8	171	O43159
GTPHSNCSSSVPPSP	RFX7	906	Q2KHR2
LSIHSLPSGPSSPFP	RGS14	41	O43566
PHTSPSPPASKSATP	TOX3	196	O15405
PVVGSPNPPSTHFAS	TFDP3	71	Q5H9I0
TAVASPPTHAAPLPA	SETD2	161	Q9BYW2
PHTPGTPKSAILVPS	MAP2	1626	P11137
SSPSPPFGHSAAVSP	TOB1	151	P50616
PHPACVPSPATTTTT	ZNF598	721	Q86UK7
GSVPLSSSPPATHFP	TOP2A	1386	P11388
GTPSATPASPPASAT	TPRN	266	Q4KMQ1
AHSSPSPPGSKSATP	TOX2	196	Q96NM4
STNPPKAPIIPHSGS	ZNF830	211	Q96NB3
PSPPSSAHSKAPHLG	ZC3H12C	726	Q9C0D7
ELHSSTLTSPGPSPP	PRR30	151	Q53SZ7
GDSVPVSPSSPHAPD	UNK	351	Q9C0B0
SPVPPALDPGHSATS	RIPOR1	496	Q6ZS17
PSPSSHSSPAPPSSS	SETBP1	291	Q9Y6X0
PGTPTPVSVAHLLSP	UPK3B	66	Q9BT76
ALAPPGPPLSSSHAV	ZNF619	496	Q8N2I2
GPPLSSSHAVVLPPS	ZNF619	501	Q8N2I2
HGSLNPPATPASSTP	ZNF438	211	Q7Z4V0
EPPSSHVSPSPTGAS	ZNF106	1161	Q9H2Y7
ESHGRTPSPSPPCSS	ULK1	396	O75385
SGPSTPLHTSSPVQG	TNS2	906	Q63HR2
GPARPSPDSSASPHS	ZNF467	326	Q7Z7K2
TTSAVPGHPSLPSLP	AVPR2	6	P30518
SGSPMAATATSPPPH	UBALD1	96	Q8TB05
PSPTPVESSDPKAGH	ZNF358	486	Q9NW07
TPGSTEHSIPTPPTS	KIAA0319	296	Q5VV43
VHSSPVATATTPPPA	MUC12	476	Q9UKN1
TPTDSPGVPPSANAH	RPS6KA2	356	Q15349
APPLLHTPQTTGSPS	MXRA5	1786	Q9NR99
HPAGTPEPPSSESSL	NACAD	266	O15069
ATTHSPTPPSPKGAP	NACA	851	E9PAV3
PGHVLSPSPSPSTNR	MYRF	906	Q9Y2G1